Vancouver, British Columbia--(Newsfile Corp. - September 8, 2026) - Market One ("Market One"), a marketing agency for public companies, shares editorial and video features on emerging growth stories across the resource, energy, and technology sectors.
Market One delivers content creation and distribution through a suite of products across video, editorial, and social media.
IDEX Metals Corp.: Drilling Four Porphyry Targets at Its Freeze Copper Project in Idaho
IDEX Metals Corp. (TSXV: IDEX) (OTCQB: IDXMF) (the "Company" or "IDEX Metals") reviewed exploration progress at its Freeze copper project in Washington County, Idaho, including completion of a property-wide induced polarization survey, the definition of multiple porphyry targets, and the start of a two-rig drill program.
The article examines IDEX Metals' 2026 drill program at Freeze, against the backdrop of U.S. copper reshoring and the inclusion of both copper and tungsten on the 2025 U.S. critical minerals list.
Cannot view this video? Visit:
https://www.youtube.com/watch?v=hzE0rXF29xI
To read the full article, please visit BNN Bloomberg at: https://www.bnnbloomberg.ca/investment-trends/2026/09/08/idex-metals-outlines-four-large-porphyry-targets-at-its-freeze-copper-project-in-idaho/
About IDEX Metals Corp.
IDEX Metals Corp. (TSXV: IDEX) (OTCQB: IDXMF) is a Vancouver-based mineral exploration company advancing a portfolio of base and precious metal projects in Idaho, USA. The company controls more than 46,000 acres across 15 properties, anchored by the Freeze copper-gold-molybdenum porphyry project in the Idaho Copper Belt. Additional projects include Amie (silver-gold epithermal) and Mineral Mountain (silver-lead-copper carbonate replacement).
Learn more at idexmetals.com.
Follow IDEX Metals on X and LinkedIn.
Contact:
Clayton Fisher
CEO & Director [email protected]
604-260-0356
About Market One
Market One is a Canadian marketing agency for public companies, delivering best-in-class content creation and distribution. The firm helps position companies for meaningful engagement through a suite of products across video, editorial, and social media. Clients benefit from increased visibility and strengthened awareness through Market One's content and relationships with industry-leading media outlets.
Learn more at marketone.ca.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/313493
Source: Market One Media Group Inc.
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Key Takeaways IEX's HST organic sales rose 12%, while orders jumped 47%, extending backlog visibility into 2027.IDEX raised its 2026 organic sales growth outlook to 5-6% on stronger HST orders and industrial demand.Acquisitions added 1% to second-quarter sales, while dividends returned value to shareholders. IDEX Corporation (IEX - Free Report) is benefiting from sustained demand in data center power, semiconductor, space and defense markets. Accretive acquisitions and shareholder-friendly policies also bode well.
IEX currently carries a Zacks Rank #2 (Buy). Let’s delve into the factors that have been aiding the firm for a while now.
Business Strength: IDEX is benefiting from demand across data center, semiconductor, space and defense markets within the Health & Science Technologies (HST) segment, while municipal water and mining continue to support the Fluid & Metering Technologies (FMT) segment. In second-quarter 2026, HST organic sales rose 12% and organic orders increased 47%, extending backlog visibility into 2027. FMT organic sales increased 1% and orders rose 11%, with water and mining gains partly offset by energy, agriculture and chemical softness. The company raised its 2026 organic sales growth outlook to 5-6% from 3-4%, supported by a larger HST order book and improving demand in its industrial businesses. This mix of secular and industrial demand is expected to support IDEX’s growth beyond the latest quarter.
Accretive Acquisition: IDEX continues to undertake acquisitions to expand its technology portfolio and reach higher-value markets. In second-quarter 2026, acquisitions added 1% to consolidated sales growth and 2% to HST sales growth, reflecting Micro-LAM, acquired in July 2025. Consolidated organic sales also rose 5% in second-quarter 2026, alongside the 1% acquisition/divestiture contribution. Micro-LAM expands IDEX’s optics technology offerings within HST. The September 2024 acquisition of Mott for $1 billion added applied materials science capabilities and broadened the company’s exposure to semiconductor fabrication, medical technologies and water purification.
In the past year, the company’s shares have gained 36.2% against the industry‘s 0.7% decline.
Image Source: Zacks Investment Research
Rewards to Shareholders: IEX is committed to returning value to shareholders through dividend payments and share repurchases. In second-quarter 2026, the company paid about $54 million in dividends and repurchased $77 million of shares. For the first six months of 2026, dividend payments totaled $106.7 million compared with $105.9 million a year earlier, while cash paid for share repurchases increased to $153.4 million from $100 million.
Estimate Revisions: The Zacks Consensus Estimate for IEX’s 2026 earnings is pegged at $8.82 per share, indicating an increase of 3.9% from the 60-day-ago figure. The consensus estimate for 2027 earnings is pegged at $9.68 per share, indicating a rise of 24.6% in the same period.
Other Stocks to ConsiderSome other top-ranked companies from the same space are discussed below:
Generac Holdings Inc. (GNRC - Free Report) presently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The company delivered a trailing four-quarter average earnings surprise of 13.7%. In the past 60 days, the consensus estimate for GNRC’s 2026 earnings has increased 8.5%.
Applied Industrial Technologies (AIT - Free Report) presently carries a Zacks Rank #2 (Buy). It has a trailing four-quarter average earnings surprise of 4.3%.
The Zacks Consensus Estimate for AIT’s fiscal 2027 earnings has increased 1.7% in the past 60 days.
Helios Technologies (HLIO - Free Report) currently carries a Zacks Rank of 2. HLIO delivered a trailing four-quarter average earnings surprise of 13.1%.
In the past 60 days, the Zacks Consensus Estimate for Helios Technologies’ 2026 earnings has increased 10.4%.
Canada Pension Plan Investment Board acquired a new position in shares of IDEX Corporation (NYSE:IEX – Free Report) in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 16,700 shares of the industrial products company’s stock, valued at approximately $3,790,000.
A number of other hedge funds have also made changes to their positions in IEX. Empowered Funds LLC lifted its stake in IDEX by 3.4% during the first quarter. Empowered Funds LLC now owns 1,646 shares of the industrial products company’s stock worth $298,000 after purchasing an additional 54 shares during the last quarter. EverSource Wealth Advisors LLC increased its stake in IDEX by 4.0% in the first quarter. EverSource Wealth Advisors LLC now owns 1,446 shares of the industrial products company’s stock valued at $274,000 after purchasing an additional 56 shares during the last quarter. Evolve Private Wealth LLC increased its stake in IDEX by 2.8% in the first quarter. Evolve Private Wealth LLC now owns 2,125 shares of the industrial products company’s stock valued at $403,000 after purchasing an additional 58 shares during the last quarter. Sanctuary Advisors LLC raised its holdings in IDEX by 2.6% during the first quarter. Sanctuary Advisors LLC now owns 2,443 shares of the industrial products company’s stock worth $463,000 after purchasing an additional 62 shares in the last quarter. Finally, Mackenzie Financial Corp raised its holdings in IDEX by 2.8% during the fourth quarter. Mackenzie Financial Corp now owns 2,562 shares of the industrial products company’s stock worth $458,000 after purchasing an additional 70 shares in the last quarter. Hedge funds and other institutional investors own 97.96% of the company’s stock.
Wall Street Analyst Weigh In IEX has been the subject of several research analyst reports. DA Davidson upped their target price on shares of IDEX from $230.00 to $240.00 and gave the company a “neutral” rating in a report on Thursday, August 6th. Oppenheimer reiterated an “outperform” rating and set a $265.00 price target on shares of IDEX in a research note on Thursday, July 30th. Weiss Ratings raised shares of IDEX from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, July 30th. Royal Bank Of Canada upped their price objective on shares of IDEX from $261.00 to $280.00 and gave the company an “outperform” rating in a research note on Thursday, July 30th. Finally, TD Cowen raised their price objective on IDEX from $260.00 to $275.00 and gave the stock a “buy” rating in a report on Thursday, July 30th. Eight research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $260.80.
View Our Latest Report on IDEX Insider Transactions at IDEX In other IDEX news, CAO Lisa M. Anderson sold 385 shares of IDEX stock in a transaction on Wednesday, August 12th. The shares were sold at an average price of $238.59, for a total value of $91,857.15. Following the transaction, the chief accounting officer directly owned 4,327 shares in the company, valued at approximately $1,032,378.93. The trade was a 8.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.50% of the company’s stock.
IDEX Price Performance Shares of NYSE IEX opened at $230.44 on Monday. The company has a current ratio of 3.05, a quick ratio of 2.15 and a debt-to-equity ratio of 0.46. IDEX Corporation has a twelve month low of $158.19 and a twelve month high of $243.80. The stock has a 50 day moving average of $228.73 and a two-hundred day moving average of $213.77. The stock has a market cap of $16.99 billion, a P/E ratio of 33.16, a P/E/G ratio of 2.17 and a beta of 0.98.
IDEX (NYSE:IEX – Get Free Report) last posted its quarterly earnings data on Wednesday, July 29th. The industrial products company reported $2.32 earnings per share for the quarter, beating the consensus estimate of $2.11 by $0.21. The business had revenue of $920.60 million during the quarter, compared to the consensus estimate of $905.38 million. IDEX had a return on equity of 15.69% and a net margin of 14.49%.The company’s revenue was up 6.4% compared to the same quarter last year. During the same period in the prior year, the company earned $2.07 earnings per share. IDEX has set its FY 2026 guidance at 8.700-8.850 EPS and its Q3 2026 guidance at 2.200-2.250 EPS. On average, research analysts forecast that IDEX Corporation will post 8.82 earnings per share for the current year.
IDEX Announces Dividend The firm also recently disclosed a quarterly dividend, which was paid on Friday, July 24th. Shareholders of record on Monday, July 6th were given a dividend of $0.73 per share. This represents a $2.92 annualized dividend and a yield of 1.3%. The ex-dividend date of this dividend was Monday, July 6th. IDEX’s dividend payout ratio (DPR) is presently 42.01%.
IDEX Profile (Free Report)
IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.
Operations at IDEX are organized into three principal segments.
Recommended Stories Five stocks we like better than IDEX Strike a Balance Between Growth and Stability With These 3 Names Ready to Rally Rubrik’s AI Security Bet Could Power the Next Leg Higher Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All Snowflake Is Up Nearly 50% in 2026—What Are Short Sellers Betting Against? Want to see what other hedge funds are holding IEX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IDEX Corporation (NYSE:IEX – Free Report).
Receive News & Ratings for IDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEX and related companies with MarketBeat.com's FREE daily email newsletter.
A month has gone by since the last earnings report for Idex (IEX - Free Report) . Shares have added about 0.1% in that time frame, underperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Idex due for a pullback? Well, first let's take a quick look at its latest earnings report in order to get a better handle on the recent drivers for IDEX Corporation before we dive into how investors and analysts have reacted as of late.
IDEX Beats Q2 Earnings Estimates on HST Momentum, Raises ViewIDEX delivered second-quarter 2026 adjusted earnings of $2.32 per share, topping the Zacks Consensus Estimate of $2.10. Adjusted earnings rose 12.1% year over year. Net sales of $920.6 million beat the consensus mark of $902.43 million by 2% and increased 6.4% from the year-ago quarter. Organic sales increased 5% year over year. Acquisitions had a positive impact of 1% on sales, while foreign currency translation had no impact.
Results were driven by solid traction in the Health & Science Technologies segment, where higher volumes in AI-linked data center power and semiconductor end markets, along with strength in space and defense, supported growth. IDEX also posted record orders of more than $1 billion, signaling improving demand.
Segmental DetailsNet sales from the Fluid & Metering Technologies segment totaled $317.1 million, up 2% year over year. The Zacks Consensus Estimate was pegged at $314 million. Organic sales increased 1% year over year. Foreign currency translation had a positive impact of 1% on sales.
Net sales from the Health & Science Technologies segment totaled $415 million, up 14% year over year. The consensus estimate was pegged at $407 million. Organic sales increased 12% year over year. Acquisitions/divestitures had a positive impact of 2% on sales, while foreign currency translation had no impact.
Net sales from the Fire & Safety/Diversified Products segment totaled $189.9 million, which decreased 1% year over year. The Zacks Consensus Estimate was pegged at $189 million. Organic sales decreased 1% on a year-over-year basis, while acquisitions/divestitures and foreign currency translation had no impact on sales.
Margin ProfileIDEX’s cost of sales increased 4.4% year over year to $493.8 million. The adjusted gross margin was 46.4%, up 110 basis points year over year, reflecting net productivity improvements, volume leverage and positive price-cost dynamics, partially offset by unfavorable mix. Selling, general and administrative expenses increased 10.1% year over year to $224.1 million.
Adjusted EBITDA rose 8.9% to $258.3 million and the adjusted EBITDA margin improved 70 basis points to 28.1%. Operating income increased 6.4% to $199.9 million, aided by improved operating performance. The operating margin was 21.7%, unchanged year over year on a rounded basis. Interest expense (net) decreased to $15.1 million from $15.6 million in the prior-year period.
Balance Sheet and Cash Flow of IDEXAt the end of the second quarter, IDEX’s cash and cash equivalents were $621.3 million compared with $580 million at the end of 2025. Long-term borrowings (net) were $1.86 billion compared with $1.82 billion at the end of 2025.
In the first six months of 2026, IDEX generated net cash of $303.7 million from operating activities, up 13.6% from the year-ago period. Capital expenditures were $40.7 million compared with $29.1 million in the prior-year period. In the same period, free cash flow was $263 million, up 10.4% year over year.
IDEX paid out dividends totaling $106.7 million in the first six months of 2026, up 0.8% year over year.
How Have Estimates Been Moving Since Then?It turns out, estimates revision have trended upward during the past month.
VGM ScoresAt this time, Idex has a average Growth Score of C, though it is lagging a bit on the Momentum Score front with a D. Following the exact same course, the stock was allocated a score of D on the value side, putting it in the bottom 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending upward for the stock, and the magnitude of these revisions looks promising. It comes with little surprise Idex has a Zacks Rank #2 (Buy). We expect an above average return from the stock in the next few months.
Bard Associates Inc. acquired a new stake in shares of IDEX Corporation (NYSE:IEX – Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 6,593 shares of the industrial products company’s stock, valued at approximately $1,496,000.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Laurel Wealth Advisors LLC acquired a new stake in shares of IDEX in the 4th quarter valued at $27,000. Optiver Holding B.V. bought a new stake in shares of IDEX in the first quarter worth about $27,000. SJS Investment Consulting Inc. raised its holdings in IDEX by 104.1% during the 1st quarter. SJS Investment Consulting Inc. now owns 149 shares of the industrial products company’s stock worth $28,000 after buying an additional 76 shares during the period. CYBER HORNET ETFs LLC acquired a new stake in shares of IDEX in the 2nd quarter valued at about $35,000. Finally, Root Financial Partners LLC increased its stake in IDEX by 57.6% in the 1st quarter. Root Financial Partners LLC now owns 208 shares of the industrial products company’s stock valued at $39,000 after buying an additional 76 shares during the last quarter. 97.96% of the stock is currently owned by institutional investors and hedge funds.
Key Headlines Impacting IDEX Here are the key news stories impacting IDEX this week:
Positive Sentiment: Analysts raised several forward earnings forecasts. Zacks Research lifted its FY2026 EPS estimate to $8.70 from $8.46, Q3 2026 to $2.20 from $2.17, Q1 2027 to $2.11 from $2.09, FY2027 to $9.21 from $9.20, and FY2028 to $10.45 from $10.27. The upgrades suggest expectations for improving earnings momentum beyond the current year. IDEX analyst estimates Positive Sentiment: Longer-term earnings growth remains a key support. The FY2028 forecast implies continued expansion from the approximately $8.70 expected for FY2026, while the company’s latest reported quarter exceeded consensus estimates for both revenue and EPS. IDEX financial information Neutral Sentiment: Board changes may increase investor focus on governance and valuation. IDEX announced a board resignation and a governance adjustment. The development does not provide a clear operating-impact signal, but investors may scrutinize leadership, capital allocation, and whether the company’s premium valuation is justified. IDEX board resignation and governance adjustment Negative Sentiment: Some estimates were reduced. Zacks cut its Q2 2027 EPS forecast to $2.33 from $2.43 and its Q2 2028 forecast to $2.43 from $2.54. These isolated reductions temper the broader upgrade story and could limit upside if investors view them as signs of uneven demand or execution. IDEX revised earnings estimates Analyst Upgrades and Downgrades Several research analysts have recently commented on the company. TD Cowen lifted their target price on IDEX from $260.00 to $275.00 and gave the stock a “buy” rating in a research note on Thursday, July 30th. Royal Bank Of Canada raised their price target on IDEX from $261.00 to $280.00 and gave the stock an “outperform” rating in a research report on Thursday, July 30th. Oppenheimer reaffirmed an “outperform” rating and issued a $265.00 price target on shares of IDEX in a research note on Thursday, July 30th. Argus upped their price objective on shares of IDEX from $250.00 to $260.00 and gave the stock a “buy” rating in a research report on Thursday, August 6th. Finally, Robert W. Baird set a $257.00 target price on shares of IDEX in a report on Thursday, April 30th. Eight analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $260.80. View Our Latest Stock Report on IDEX
IDEX Trading Up 0.4% Shares of IDEX stock opened at $234.57 on Friday. IDEX Corporation has a 12-month low of $158.19 and a 12-month high of $243.80. The company has a market capitalization of $17.29 billion, a P/E ratio of 33.75, a price-to-earnings-growth ratio of 2.21 and a beta of 0.98. The stock has a fifty day simple moving average of $227.88 and a 200 day simple moving average of $212.87. The company has a current ratio of 3.05, a quick ratio of 2.15 and a debt-to-equity ratio of 0.46.
IDEX (NYSE:IEX – Get Free Report) last posted its quarterly earnings data on Wednesday, July 29th. The industrial products company reported $2.32 EPS for the quarter, beating the consensus estimate of $2.11 by $0.21. The business had revenue of $920.60 million for the quarter, compared to the consensus estimate of $905.38 million. IDEX had a return on equity of 15.69% and a net margin of 14.49%.IDEX’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.07 earnings per share. IDEX has set its FY 2026 guidance at 8.700-8.850 EPS and its Q3 2026 guidance at 2.200-2.250 EPS. On average, sell-side analysts anticipate that IDEX Corporation will post 8.82 earnings per share for the current fiscal year.
IDEX Announces Dividend The business also recently announced a quarterly dividend, which was paid on Friday, July 24th. Investors of record on Monday, July 6th were given a $0.73 dividend. The ex-dividend date was Monday, July 6th. This represents a $2.92 annualized dividend and a yield of 1.2%. IDEX’s payout ratio is 42.01%.
Insider Buying and Selling In other IDEX news, CAO Lisa M. Anderson sold 385 shares of IDEX stock in a transaction dated Wednesday, August 12th. The stock was sold at an average price of $238.59, for a total transaction of $91,857.15. Following the completion of the sale, the chief accounting officer owned 4,327 shares of the company’s stock, valued at $1,032,378.93. The trade was a 8.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.50% of the stock is currently owned by corporate insiders.
IDEX Profile (Free Report)
IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.
Operations at IDEX are organized into three principal segments.
Featured Stories Five stocks we like better than IDEX Blueprint for a Boom: SEC Clears the Crypto Runway Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss Advance Auto Parts Plunged, But Its Turnaround Is Still Working Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates? Want to see what other hedge funds are holding IEX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IDEX Corporation (NYSE:IEX – Free Report).
Receive News & Ratings for IDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEX and related companies with MarketBeat.com's FREE daily email newsletter.
Investors might want to bet on Idex (IEX - Free Report) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.
The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.
Since a changing earnings picture is a powerful factor influencing near-term stock price movements, the Zacks rating system is very useful for individual investors. They may find it difficult to make decisions based on rating upgrades by Wall Street analysts, as these are mostly driven by subjective factors that are hard to see and measure in real time.
As such, the Zacks rating upgrade for Idex is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price.
Most Powerful Force Impacting Stock PricesThe change in a company's future earnings potential, as reflected in earnings estimate revisions, has proven to be strongly correlated with the near-term price movement of its stock. The influence of institutional investors has a partial contribution to this relationship, as these big professionals use earnings and earnings estimates to calculate the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their bulk investment action then leads to price movement for the stock.
Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for Idex imply an improvement in the company's underlying business. Investors should show their appreciation for this improving business trend by pushing the stock higher.
Harnessing the Power of Earnings Estimate RevisionsEmpirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, so it could be truly rewarding if such revisions are tracked for making an investment decision. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>> .
Earnings Estimate Revisions for IdexFor the fiscal year ending December 2026, this maker of the Jaws of Life device and other engineered products is expected to earn $8.71 per share, which is unchanged compared with the year-ago reported number.
Analysts have been steadily raising their estimates for Idex. Over the past three months, the Zacks Consensus Estimate for the company has increased 4%.
Bottom LineUnlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of "buy" and "sell" ratings for its entire universe of more than 4,000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a "Strong Buy" rating and the next 15% get a "Buy" rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.
You can learn more about the Zacks Rank here >>>
The upgrade of Idex to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
Empowered Funds LLC lifted its position in shares of IDEX Corporation (NYSE:IEX – Free Report) by 95.7% during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 8,418 shares of the industrial products company’s stock after buying an additional 4,116 shares during the quarter. Empowered Funds LLC’s holdings in IDEX were worth $1,596,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Evelyn Partners Investment Management LLP grew its holdings in shares of IDEX by 10.8% in the first quarter. Evelyn Partners Investment Management LLP now owns 205,291 shares of the industrial products company’s stock valued at $38,913,000 after purchasing an additional 19,932 shares in the last quarter. Quantinno Capital Management LP lifted its holdings in IDEX by 281.4% during the first quarter. Quantinno Capital Management LP now owns 114,480 shares of the industrial products company’s stock worth $21,700,000 after buying an additional 84,465 shares during the period. Polar Asset Management Partners Inc. purchased a new stake in shares of IDEX during the 1st quarter valued at $2,047,000. SummitTX Capital L.P. raised its holdings in shares of IDEX by 15.6% in the first quarter. SummitTX Capital L.P. now owns 20,197 shares of the industrial products company’s stock worth $3,828,000 after buying an additional 2,732 shares during the last quarter. Finally, Quadcap Wealth Management LLC purchased a new stake in IDEX in the first quarter valued at $233,000. Institutional investors own 97.96% of the company’s stock.
Insiders Place Their Bets In related news, CEO Eric D. Ashleman sold 15,385 shares of the business’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $215.22, for a total transaction of $3,311,159.70. Following the transaction, the chief executive officer directly owned 66,658 shares in the company, valued at $14,346,134.76. The trade was a 18.75% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 0.50% of the stock is currently owned by company insiders.
IDEX Trading Up 0.3% IDEX stock opened at $234.34 on Friday. The firm has a 50 day simple moving average of $223.71 and a 200-day simple moving average of $210.08. The stock has a market capitalization of $17.28 billion, a PE ratio of 33.72, a price-to-earnings-growth ratio of 2.20 and a beta of 0.98. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.05 and a quick ratio of 2.15. IDEX Corporation has a 12-month low of $157.25 and a 12-month high of $243.80.
IDEX (NYSE:IEX – Get Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The industrial products company reported $2.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.11 by $0.21. IDEX had a net margin of 14.49% and a return on equity of 15.69%. The firm had revenue of $920.60 million for the quarter, compared to analyst estimates of $905.38 million. During the same quarter in the previous year, the business posted $2.07 earnings per share. The firm’s quarterly revenue was up 6.4% compared to the same quarter last year. IDEX has set its FY 2026 guidance at 8.700-8.850 EPS and its Q3 2026 guidance at 2.200-2.250 EPS. As a group, equities research analysts expect that IDEX Corporation will post 8.84 EPS for the current fiscal year.
IDEX Dividend Announcement The company also recently announced a quarterly dividend, which was paid on Friday, July 24th. Shareholders of record on Monday, July 6th were given a dividend of $0.73 per share. The ex-dividend date of this dividend was Monday, July 6th. This represents a $2.92 dividend on an annualized basis and a yield of 1.2%. IDEX’s payout ratio is currently 42.01%.
Wall Street Analysts Forecast Growth Several research analysts recently commented on the company. TD Cowen increased their price objective on IDEX from $260.00 to $275.00 and gave the company a “buy” rating in a research note on Thursday, July 30th. Stifel Nicolaus increased their price target on shares of IDEX from $257.00 to $268.00 and gave the stock a “buy” rating in a report on Thursday, July 30th. DA Davidson raised their price target on IDEX from $230.00 to $240.00 and gave the company a “neutral” rating in a research report on Thursday. Argus upped their price objective on shares of IDEX from $250.00 to $260.00 and gave the company a “buy” rating in a research note on Thursday. Finally, Royal Bank Of Canada increased their price target on shares of IDEX from $261.00 to $280.00 and gave the stock an “outperform” rating in a research note on Thursday, July 30th. Seven analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, IDEX currently has an average rating of “Moderate Buy” and a consensus target price of $258.67.
Get Our Latest Report on IEX
IDEX Profile (Free Report)
IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.
Operations at IDEX are organized into three principal segments.
See Also Five stocks we like better than IDEX Datadog’s Drop Says More About Expectations Than Earnings D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for IDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEX and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINECetera Investment Advisers Sells 21,428 Shares of FT Vest Nasdaq-100 Moderate Buffer ETF – May $QMMY
NEXT HEADLINE »Cetera Investment Advisers Buys 5,788 Shares of Owens Corning Inc $OC
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.
Even though momentum is a popular stock characteristic, it can be tough to define. Debate surrounding which are the best and worst metrics to focus on is lengthy, but the Zacks Momentum Style Score, part of the Zacks Style Scores, helps address this issue for us.
Below, we take a look at Idex (IEX - Free Report) , a company that currently holds a Momentum Style Score of A. We also talk about price change and earnings estimate revisions, two of the main aspects of the Momentum Style Score.
It's also important to note that Style Scores work as a complement to the Zacks Rank, our stock rating system that has an impressive track record of outperformance. Idex currently has a Zacks Rank of #2 (Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of "A or B" outperform the market over the following one-month period.
You can see the current list of Zacks #1 Rank Stocks here >>>
Set to Beat the Market? In order to see if IEX is a promising momentum pick, let's examine some Momentum Style elements to see if this maker of the Jaws of Life device and other engineered products holds up.
Looking at a stock's short-term price activity is a great way to gauge if it has momentum, since this can reflect both the current interest in a stock and if buyers or sellers have the upper hand at the moment. It is also useful to compare a security to its industry, as this can help investors pinpoint the top companies in a particular area.
For IEX, shares are up 3.22% over the past week while the Zacks Manufacturing - General Industrial industry is flat over the same time period. Shares are looking quite well from a longer time frame too, as the monthly price change of 8.51% compares favorably with the industry's 2.26% performance as well.
Considering longer term price metrics, like performance over the last three months or year, can be advantageous as well. Shares of Idex have increased 11.67% over the past quarter, and have gained 48.37% in the last year. On the other hand, the S&P 500 has only moved 6.65% and 23.84%, respectively.
Investors should also pay attention to IEX's average 20-day trading volume. Volume is a useful item in many ways, and the 20-day average establishes a good price-to-volume baseline; a rising stock with above average volume is generally a bullish sign, whereas a declining stock on above average volume is typically bearish. IEX is currently averaging 757,825 shares for the last 20 days.
Earnings OutlookThe Zacks Momentum Style Score also takes into account trends in estimate revisions, in addition to price changes. Please note that estimate revision trends remain at the core of Zacks Rank as well. A nice path here can help show promise, and we have recently been seeing that with IEX.
Over the past two months, 3 earnings estimates moved higher compared to none lower for the full year. These revisions helped boost IEX's consensus estimate, increasing from $8.49 to $8.61 in the past 60 days. Looking at the next fiscal year, 4 estimates have moved upwards while there have been no downward revisions in the same time period.
Bottom LineGiven these factors, it shouldn't be surprising that IEX is a #2 (Buy) stock and boasts a Momentum Score of A. If you're looking for a fresh pick that's set to soar in the near-term, make sure to keep Idex on your short list.
Amundi trimmed its holdings in IDEX Corporation (NYSE:IEX – Free Report) by 18.0% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,219,400 shares of the industrial products company’s stock after selling 268,259 shares during the quarter. Amundi owned about 1.65% of IDEX worth $231,229,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors also recently bought and sold shares of IEX. Laurel Wealth Advisors LLC bought a new position in shares of IDEX during the fourth quarter valued at approximately $27,000. SJS Investment Consulting Inc. boosted its position in shares of IDEX by 104.1% in the 1st quarter. SJS Investment Consulting Inc. now owns 149 shares of the industrial products company’s stock worth $28,000 after purchasing an additional 76 shares in the last quarter. Cromwell Holdings LLC boosted its position in shares of IDEX by 41.1% in the 4th quarter. Cromwell Holdings LLC now owns 199 shares of the industrial products company’s stock worth $35,000 after purchasing an additional 58 shares in the last quarter. CYBER HORNET ETFs LLC purchased a new stake in shares of IDEX in the 2nd quarter worth approximately $35,000. Finally, Root Financial Partners LLC increased its position in IDEX by 57.6% during the 1st quarter. Root Financial Partners LLC now owns 208 shares of the industrial products company’s stock valued at $39,000 after buying an additional 76 shares in the last quarter. 97.96% of the stock is owned by hedge funds and other institutional investors.
Key Headlines Impacting IDEX Here are the key news stories impacting IDEX this week:
Positive Sentiment: Quarterly earnings and revenue beat estimates. IDEX reported adjusted EPS of $2.32, versus the $2.11 consensus, while revenue reached $920.6 million, ahead of estimates near $905.4 million and up 6.4% year over year. IDEX quarterly earnings report Positive Sentiment: Demand trends improved significantly. Record orders rose approximately 29% reported and 28% organically to about $1.07 billion. Strength in data centers, semiconductors, space and defense—particularly within Health & Science Technologies—supports better visibility into future sales. Positive Sentiment: Management raised its full-year outlook. IDEX now expects 2026 organic sales growth of 5% to 6% and adjusted diluted EPS of $8.70 to $8.85, above its prior $8.35-$8.55 range and the approximately $8.49 analyst consensus. Third-quarter EPS guidance of $2.20-$2.25 also exceeds consensus near $2.19. IDEX raises annual profit outlook Positive Sentiment: Analysts increased their price targets. TD Cowen raised its target from $260 to $275 and assigned a “buy” rating, while Royal Bank of Canada lifted its target from $261 to $280 and maintained an “outperform” rating. The new targets imply roughly 18% to 20% potential upside from the referenced trading level. Analyst price-target updates from Benzinga Neutral Sentiment: Valuation remains elevated. IDEX trades at approximately 34.6 times earnings, meaning continued upside may depend on the company converting strong orders and end-market demand into sustained earnings growth. Analyst Ratings Changes IEX has been the subject of a number of recent research reports. Seaport Research Partners reiterated a “buy” rating and set a $250.00 price objective on shares of IDEX in a research note on Tuesday, May 5th. Weiss Ratings upgraded IDEX from a “hold (c)” rating to a “hold (c+)” rating in a report on Wednesday, June 24th. Stifel Nicolaus lifted their price target on IDEX from $257.00 to $268.00 and gave the stock a “buy” rating in a research report on Thursday. TD Cowen increased their price objective on shares of IDEX from $260.00 to $275.00 and gave the company a “buy” rating in a research report on Thursday. Finally, Royal Bank Of Canada raised their price objective on shares of IDEX from $261.00 to $280.00 and gave the company an “outperform” rating in a research note on Thursday. Six investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $251.44.
Get Our Latest Stock Analysis on IEX
Insider Activity at IDEX In related news, CEO Eric D. Ashleman sold 15,385 shares of the company’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $215.22, for a total transaction of $3,311,159.70. Following the completion of the sale, the chief executive officer owned 66,658 shares in the company, valued at approximately $14,346,134.76. This represents a 18.75% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.50% of the stock is owned by insiders.
IDEX Stock Up 1.9% IEX opened at $233.79 on Friday. The stock has a market capitalization of $17.30 billion, a price-to-earnings ratio of 33.64, a PEG ratio of 2.18 and a beta of 0.98. The firm has a 50 day moving average price of $220.83 and a 200-day moving average price of $208.39. IDEX Corporation has a twelve month low of $157.25 and a twelve month high of $243.80. The company has a quick ratio of 2.40, a current ratio of 3.05 and a debt-to-equity ratio of 0.46.
IDEX (NYSE:IEX – Get Free Report) last issued its earnings results on Wednesday, July 29th. The industrial products company reported $2.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.11 by $0.21. IDEX had a net margin of 14.49% and a return on equity of 15.69%. The company had revenue of $920.60 million for the quarter, compared to analysts’ expectations of $905.38 million. During the same quarter last year, the company posted $2.07 earnings per share. The firm’s quarterly revenue was up 6.4% on a year-over-year basis. IDEX has set its FY 2026 guidance at 8.700-8.850 EPS and its Q3 2026 guidance at 2.200-2.250 EPS. Equities research analysts forecast that IDEX Corporation will post 8.78 earnings per share for the current year.
IDEX Announces Dividend The company also recently disclosed a quarterly dividend, which was paid on Friday, July 24th. Investors of record on Monday, July 6th were issued a $0.73 dividend. The ex-dividend date of this dividend was Monday, July 6th. This represents a $2.92 annualized dividend and a dividend yield of 1.2%. IDEX’s payout ratio is presently 43.20%.
IDEX Profile (Free Report)
IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.
Operations at IDEX are organized into three principal segments.
Featured Articles Five stocks we like better than IDEX Microsoft Just Flipped the AI Spending Narrative Overnight Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling? Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes Want to see what other hedge funds are holding IEX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IDEX Corporation (NYSE:IEX – Free Report).
Receive News & Ratings for IDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEX and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEAmundi Buys 459,980 Shares of Garmin Ltd. $GRMN
IDEX Corporation (NYSE:IEX – Get Free Report)’s stock price reached a new 52-week high during trading on Wednesday following a better than expected earnings announcement. The stock traded as high as $232.55 and last traded at $239.8090, with a volume of 608 shares. The stock had previously closed at $224.65.
The industrial products company reported $2.32 EPS for the quarter, beating analysts’ consensus estimates of $2.11 by $0.21. IDEX had a return on equity of 15.29% and a net margin of 14.38%.The firm had revenue of $920.60 million for the quarter, compared to analyst estimates of $905.38 million. During the same quarter in the prior year, the firm earned $2.07 earnings per share. IDEX’s revenue for the quarter was up 6.4% on a year-over-year basis. IDEX has set its FY 2026 guidance at 8.700-8.850 EPS and its Q3 2026 guidance at 2.200-2.250 EPS.
IDEX Dividend Announcement The firm also recently disclosed a quarterly dividend, which was paid on Friday, July 24th. Stockholders of record on Monday, July 6th were issued a $0.73 dividend. This represents a $2.92 annualized dividend and a dividend yield of 1.3%. The ex-dividend date of this dividend was Monday, July 6th. IDEX’s dividend payout ratio is 43.20%.
IDEX News Summary Here are the key news stories impacting IDEX this week:
Positive Sentiment: IDEX reported second-quarter adjusted EPS of $2.32, exceeding the $2.11 consensus estimate, while revenue of $920.6 million topped expectations of approximately $905.4 million. Revenue increased 6% year over year, and adjusted EBITDA margin expanded to 28.1%. IDEX Q2 Earnings and Revenues Top Estimates Positive Sentiment: Orders rose 28% organically to a record roughly $1.07 billion, pointing to strong demand and better order visibility for upcoming quarters. Management cited continued strength tied to data centers, semiconductors, and space and defense markets. IDEX rises after Q2 earnings beat and guidance hike Positive Sentiment: Management raised its fiscal 2026 adjusted EPS guidance to $8.70-$8.85, above the prior $8.35-$8.55 range and the $8.49 analyst consensus. Full-year organic sales growth is now expected at 5%-6%; third-quarter EPS guidance of $2.20-$2.25 also slightly exceeds consensus. IDEX Q2 2026 Earnings Call Highlights Neutral Sentiment: IDEX returned capital through approximately $77 million of share repurchases and $54 million in dividends, supporting shareholder returns but leaving less cash for other uses. IDEX Q2 sales rise to record $921 million Negative Sentiment: Recent reported insider activity showed two open-market sales by CEO Eric Ashleman totaling 15,385 shares, with no purchases. This is a secondary sentiment concern, although the sales may reflect personal liquidity or scheduled transactions. Analyst Upgrades and Downgrades IEX has been the subject of a number of research reports. TD Cowen boosted their target price on shares of IDEX from $250.00 to $260.00 and gave the company a “buy” rating in a research report on Thursday, April 30th. Weiss Ratings raised IDEX from a “hold (c)” rating to a “hold (c+)” rating in a research report on Wednesday, June 24th. Oppenheimer lifted their price objective on IDEX from $250.00 to $260.00 and gave the company an “outperform” rating in a research note on Tuesday, July 21st. Robert W. Baird set a $257.00 target price on IDEX in a research note on Thursday, April 30th. Finally, Stifel Nicolaus raised their target price on IDEX from $250.00 to $257.00 and gave the stock a “buy” rating in a report on Monday, July 20th. Six analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $244.00.
Check Out Our Latest Analysis on IEX
Insider Activity In related news, CEO Eric D. Ashleman sold 15,385 shares of the stock in a transaction on Monday, May 11th. The shares were sold at an average price of $215.22, for a total transaction of $3,311,159.70. Following the sale, the chief executive officer directly owned 66,658 shares of the company’s stock, valued at approximately $14,346,134.76. This represents a 18.75% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. 0.50% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Deprince Race & Zollo Inc. increased its position in shares of IDEX by 4.3% during the fourth quarter. Deprince Race & Zollo Inc. now owns 359,152 shares of the industrial products company’s stock worth $63,908,000 after purchasing an additional 14,952 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. raised its stake in IDEX by 4.5% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 160,520 shares of the industrial products company’s stock valued at $28,743,000 after purchasing an additional 6,901 shares during the last quarter. SG Americas Securities LLC lifted its holdings in IDEX by 2,690.4% in the 4th quarter. SG Americas Securities LLC now owns 32,508 shares of the industrial products company’s stock valued at $5,784,000 after purchasing an additional 31,343 shares in the last quarter. Baader Bank Aktiengesellschaft lifted its holdings in IDEX by 27.5% in the 4th quarter. Baader Bank Aktiengesellschaft now owns 27,809 shares of the industrial products company’s stock valued at $4,948,000 after purchasing an additional 6,000 shares in the last quarter. Finally, RNC Capital Management LLC boosted its stake in IDEX by 227.3% during the 4th quarter. RNC Capital Management LLC now owns 19,807 shares of the industrial products company’s stock worth $3,524,000 after purchasing an additional 13,755 shares during the last quarter. Hedge funds and other institutional investors own 97.96% of the company’s stock.
IDEX Stock Performance The company has a market cap of $16.97 billion, a price-to-earnings ratio of 33.92, a PEG ratio of 2.21 and a beta of 0.98. The firm’s 50 day simple moving average is $220.26 and its 200-day simple moving average is $208.04. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.40 and a current ratio of 3.39.
IDEX Company Profile (Get Free Report)
IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.
Operations at IDEX are organized into three principal segments.
Recommended Stories Five stocks we like better than IDEX Why SK hynix Could Be the Best AI Chip Stock to Buy Now Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead? Why Bloom Energy May Be the Most Important AI Infrastructure Stock Receive News & Ratings for IDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEX and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINELiberty Broadband (LBRDK) to Announce Earnings on Thursday
NEXT HEADLINE »O-I Glass (NYSE:OI) Sets New 1-Year Low After Earnings Miss
Industrial Tech Crossovers: When Manufacturing Meets InnovationIDEX NYSE: IEX reported second-quarter 2026 results that exceeded its expectations, supported by growth in its Health & Science Technologies segment, stronger orders and operational execution. The company raised its full-year outlook for organic sales growth, adjusted EBITDA margin and adjusted earnings per share.
Organic sales increased 5% year over year in the second quarter, while adjusted EBITDA margin expanded 70 basis points to 28.1%. Adjusted earnings per share rose 12% to $2.32. President and Chief Executive Officer Eric Ashleman said the results were driven most significantly by higher volumes in the company’s growth platforms.
Get IDEX alerts:
Orders grew 28% organically across IDEX, reaching a record level of more than $1 billion. Each of the company’s three reporting segments posted double-digit order growth, led by Health & Science Technologies, or HST, where orders rose 47% organically.
Growth platforms drive HST demand Ashleman said HST demand was concentrated in data center, semiconductor, and space and defense applications. Those application sets collectively represented more than one-third of HST revenue year to date, according to the company.
IDEX cited demand for Performance Pneumatics products supporting primary and standby power generation connected to data center construction, as well as liquid-cooling flow-control systems used in data center infrastructure. In semiconductor markets, the company provides high-purity gas filtration, sealing, optical detection and thermal-management products for process tools, inspection systems and metrology equipment.
The company said its Mott filtration business has increased recurring revenue within HST’s semiconductor portfolio to approximately 50%. Ashleman also pointed to engineered components for space and defense applications, where IDEX is seeking to establish specifications for emerging technologies that can create longer-term revenue streams.
HST organic revenue rose 12% in the quarter, while its adjusted EBITDA margin expanded 270 basis points year over year. Sean Gillen, IDEX’s senior vice president and chief financial officer, said the margin performance reflected volume leverage and positive price-cost dynamics, including the effect of tariff refunds.
During the question-and-answer session, Ashleman said HST’s increasing order backlog includes some customer demand extending into 2027, particularly in data-center-related pneumatics. He cautioned, however, that much of IDEX remains a rapid-replenishment business with short lead times.
Tariff refunds affected reported results IDEX received refunds during the quarter related to tariffs under the International Emergency Economic Powers Act, or IEEPA. Gillen said the refunds lowered cost of sales, while interest paid by the U.S. government slightly reduced net interest expense. In some cases, IDEX expects to provide customer rebates, which are accounted for as a reduction in sales.
The combined net effect added $0.08 to adjusted EPS during the quarter. Customer rebates tied to the refunds reduced reported organic growth by 2 percentage points.
Gillen said tariff refunds provided a 130-basis-point benefit to consolidated adjusted EBITDA margin. Excluding the tariff-related effects, adjusted EBITDA margin was toward the high end of the company’s prior guidance range of 26.5% to 27%.
The company said it expects most of the tariff-refund and related rebate activity to remain confined to the second quarter.
FMT and FSDP orders improve despite mixed sales trends Fluid & Metering Technologies, or FMT, posted organic order growth of 11% and organic sales growth of 1%. The water platform and mining-related operations supported sales, while agricultural, chemical and energy end markets remained softer.
Ashleman said IDEX’s municipal water business continued to benefit from demand for wastewater analytics and inspection tools. He also said the company’s high-purity water pumping and heating systems used in semiconductor applications had added momentum to the water platform. The company reported double-digit growth for the platform in the second quarter.
FMT adjusted EBITDA margin declined 20 basis points year over year, as unfavorable mix more than offset tariff-refund benefits and productivity gains. Gillen noted that tariff refunds provided a 180-basis-point benefit to the segment’s margin, and said underlying margin performance was in line with IDEX’s expectations.
Fire & Safety/Diversified Products, or FSDP, reported 19% organic order growth, aided by aerospace demand at BAND-IT, including a significant blanket order, and continued momentum in North American fire and integrated-system orders. Organic sales declined 1%, reflecting lower dispensing activity and softer European rescue markets, partly offset by aerospace strength.
FSDP adjusted EBITDA margin declined 50 basis points, with unfavorable mix and volume deleverage partially offset by productivity improvements. Tariff refunds benefited the segment’s margin by 120 basis points.
Ashleman said the company was seeing early signs of broader industrial improvement in smaller, distribution-driven orders late in the second quarter and into July. He said this activity had followed earlier strength in longer-lead-time projects, including municipal water, mining and data-center-related applications.
Outlook and capital allocation IDEX increased its full-year 2026 organic growth outlook to 5% to 6%, from its previous forecast of 3% to 4%. The company now expects approximately low-double-digit growth in HST, while projecting FMT and FSDP to be slightly higher year over year.
Adjusted EBITDA margin is expected to be 27% to 27.3%, up from prior guidance of 26.5% to 27%. Adjusted EPS is expected to be $8.70 to $8.85, compared with previous guidance of $8.35 to $8.55. For the third quarter, IDEX expects organic growth of 5% to 7%, adjusted EBITDA margin of 27% to 27.5%, and adjusted EPS of $2.20 to $2.25. The company generated $177 million in free cash flow during the quarter and ended the period with more than $1.1 billion of liquidity. Gross leverage declined to 1.9 times from 2.1 times a year earlier.
IDEX spent $77 million repurchasing shares and paid $54 million in dividends during the second quarter. Gillen said the company plans to maintain quarterly share repurchases at roughly $75 million through the remainder of 2026, while retaining flexibility based on leverage, bolt-on acquisition opportunities and portfolio decisions.
Capital expenditures are now expected to total approximately $110 million for 2026, up from the prior $90 million forecast. Ashleman said most of the incremental spending will support HST capacity and capabilities for anticipated demand in 2027, 2028 and beyond.
About IDEX (NYSE:IEX)IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company's core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.
Operations at IDEX are organized into three principal segments.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in IDEX Right Now?Before you consider IDEX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IDEX wasn't on the list.
While IDEX currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Key Takeaways IDEX beat second-quarter earnings and sales estimates, with organic sales rising 5% year over year.IEX posted record orders above $1 billion, supported by AI data centers, semiconductors, space and defense.IDEX raised 2026 organic sales and adjusted earnings guidance after strong second-quarter results. IDEX Corporation (IEX - Free Report) delivered second-quarter 2026 adjusted earnings of $2.32 per share, topping the Zacks Consensus Estimate of $2.10. The metric rose 12.1% year over year. Net sales of $920.6 million beat the consensus mark of $902.43 million by 2% and increased 6.4% from the year-ago quarter. Organic sales increased 5% year over year. Acquisitions had a positive impact of 1% on sales, while foreign currency translation had no impact.
Results were driven by solid traction in the Health & Science Technologies segment, where higher volumes in AI-linked data center power and semiconductor end markets, along with strength in space and defense, supported growth. IDEX also posted record orders of more than $1 billion, signaling improving demand.
Segmental DetailsNet sales from the Fluid & Metering Technologies segment totaled $317.1 million, up 2% year over year. The Zacks Consensus Estimate was pegged at $314 million. Organic sales increased 1% year over year. Foreign currency translation had a positive impact of 1% on sales.
Net sales from the Health & Science Technologies segment totaled $415 million, up 14% year over year. The consensus estimate was pegged at $407 million. Organic sales increased 12% year over year. Acquisitions/divestitures had a positive impact of 2% on sales, while foreign currency translation had no impact.
Net sales from the Fire & Safety/Diversified Products segment totaled $189.9 million, which decreased 1% year over year. The Zacks Consensus Estimate was pegged at $189 million. Organic sales decreased 1% on a year-over-year basis, while acquisitions/divestitures and foreign currency translation had no impact on sales.
IDEX’s Margin ProfileIDEX’s cost of sales increased 4.4% year over year to $493.8 million. The adjusted gross margin was 46.4%, up 110 basis points year over year, reflecting net productivity improvements, volume leverage and positive price-cost dynamics, partially offset by unfavorable mix. Selling, general and administrative expenses increased 10.1% year over year to $224.1 million.
Adjusted EBITDA rose 8.9% to $258.3 million and the adjusted EBITDA margin improved 70 basis points to 28.1%. Operating income increased 6.4% to $199.9 million, aided by improved operating performance. The operating margin was 21.7%, unchanged year over year on a rounded basis. Interest expenses (net) decreased to $15.1 million from $15.6 million in the prior-year period.
Balance Sheet and Cash Flow of IDEXWhile exiting the second quarter, IDEX’s cash and cash equivalents were $621.3 million compared with $580 million at the end of 2025. Long-term borrowings (net) were $1.86 billion compared with $1.82 billion at the end of 2025.
In the first six months of 2026, IDEX generated net cash of $303.7 million from operating activities, up 13.6% from the year-ago period. Capital expenditures were $40.7 million compared with $29.1 million in the prior-year period. In the same period, free cash flow was $263 million, up 10.4% year over year.
IDEX paid out dividends totaling $106.7 million in the first six months of 2026, up 0.8% year over year.
IDEX’s Raised 2026 Outlook Reflects ConfidenceThe company raised its full-year 2026 guidance, projecting organic sales growth of 5-6% compared with prior expectations of 3-4%. The company also lifted its full-year adjusted earnings outlook to $8.70-$8.85 per share from $8.35-$8.55 previously.
For the third quarter of 2026, IDEX expects organic sales to increase 5-7% from the year-ago period and adjusted earnings in the range of $2.20-$2.25 per share.
IEX’s Zacks RankPerformance of Other CompaniesConstellium SE (CSTM - Free Report) came out with quarterly earnings of $1.04 per share in the second quarter of 2026, beating the Zacks Consensus Estimate of $0.91 per share. This compares with earnings of $0.25 per share a year ago.
Constellium posted revenues of $2.75 billion for the quarter ended June 2026, missing the Zacks Consensus Estimate by 3.5%. This compares with year-ago revenues of $2.1 billion.
Generac Holdings Inc. (GNRC - Free Report) came out with quarterly earnings of $2.91 per share in the second quarter of 2026, beating the Zacks Consensus Estimate of $1.95 per share. This compares with earnings of $1.65 per share a year ago.
Generac Holdings posted revenues of $1.17 billion for the quarter ended June 2026, missing the Zacks Consensus Estimate by 0.37%. This compares with year-ago revenues of $1.06 billion.
Graco Inc. (GGG - Free Report) reported second-quarter 2026 adjusted earnings of 91 cents per share, up 17% from 78 cents in the year-ago quarter. The bottom line surpassed the Zacks Consensus Estimate of 81 cents by 12.4%.
The company’s net sales rose 3% year over year to $590.6 million but lagged the consensus estimate of $609 million by 3%. Organic order backlog (excluding acquisitions) rose 28% from the end of 2025.
IDEX Corporation (IEX) Q2 2026 Earnings Call July 29, 2026 9:00 AM EDT
Company Participants
James Giannakouros - Vice President of Investor Relations
Eric Ashleman - CEO, President & Director
Sean Gillen - Senior VP & CFO
Conference Call Participants
Michael Halloran - Robert W. Baird & Co. Incorporated, Research Division
Deane Dray - RBC Capital Markets, Research Division
Bryan Blair - Oppenheimer & Co. Inc., Research Division
Joseph Giordano - TD Cowen, Research Division
Robert Wertheimer - Melius Research LLC
Nathan Jones - Stifel, Nicolaus & Company, Incorporated, Research Division
Vladimir Bystricky - Citigroup Inc., Research Division
Andrew Buscaglia - BNP Paribas, Research Division
Daniel DiCicco - BMO Capital Markets Equity Research
Brett Linzey - Mizuho Securities USA LLC, Research Division
Presentation
Operator
Hello, everyone. Thank you for joining us, and welcome to the IDEX Corporation Second Quarter 2026 Earnings Conference Call. [Operator Instructions]
I will now hand the conference over to Jim Giannakouros, VP Investor Relations. Jim, please go ahead.
James Giannakouros
Vice President of Investor Relations
Good morning, everyone, and welcome to IDEX's Second Quarter 2026 Earnings Conference Call. We released our second quarter financial results earlier this morning, and you can find both our press release and earnings call slide presentation in the Investors section of our website, idexcorp.com.
On the call with me today are Eric Ashleman, President and Chief Executive Officer of IDEX; and Sean Gillen, our Chief Financial Officer. Today's call will begin with Eric providing highlights of our second quarter results and an update on our business outlook and strategies. Then Sean will discuss additional financial details and our updated outlook for 2026. Following our prepared remarks, we will open the line for questions.
But before we begin, please refer to Slide 2 of our presentation, where we note that comments today will include forward-looking statements based on current expectations. Actual results could differ
For the quarter ended June 2026, Idex (IEX - Free Report) reported revenue of $920.6 million, up 6.4% over the same period last year. EPS came in at $2.32, compared to $2.07 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $902.43 million, representing a surprise of +2.01%. The company delivered an EPS surprise of +10.48%, with the consensus EPS estimate being $2.10.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Idex performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Net Sales - Organic impact - YoY change: 5% versus 3.4% estimated by two analysts on average.Net Sales- Fluid & Metering Technologies (FMT): $317.1 million compared to the $313.81 million average estimate based on three analysts. The reported number represents a change of +2% year over year.Net Sales- Intersegment sales/ Eliminations: $-1.4 million versus the three-analyst average estimate of $-2.37 million. The reported number represents a year-over-year change of -39.1%.Net Sales- Fire & Safety/Diversified Products (FSDP): $189.9 million versus the three-analyst average estimate of $188.69 million. The reported number represents a year-over-year change of -0.8%.Net Sales- Health & Science Technologies (HST): $415 million versus $406.67 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +13.6% change.Adjusted EBITDA- Fluid & Metering Technologies (FMT): $110.3 million compared to the $105.04 million average estimate based on three analysts.Adjusted EBITDA- Corporate: $-26.2 million versus $-25.38 million estimated by three analysts on average.Adjusted EBITDA- Fire & Safety/Diversified Products (FSDP): $54.9 million versus $54.1 million estimated by three analysts on average.Adjusted EBITDA- Health & Science Technologies (HST): $119.3 million compared to the $108.88 million average estimate based on three analysts.View all Key Company Metrics for Idex here>>>
Shares of Idex have returned -1% over the past month versus the Zacks S&P 500 composite's +1.9% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
NORTHBROOK, Ill.--(BUSINESS WIRE)--IDEX Corporation (NYSE: IEX) today announced its financial results for the three-month period ended June 30, 2026. “We are very pleased to see continued results momentum as our IDEX teams drove another quarter of strong sales and earnings growth. Orders of over $1 billion in the quarter were a record as we continue to see elevated demand across the advantaged markets where we've focused our investments and capabilities,” said Eric D. Ashleman, IDEX Corporation.
Idex (IEX - Free Report) came out with quarterly earnings of $2.32 per share, beating the Zacks Consensus Estimate of $2.1 per share. This compares to earnings of $2.07 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +10.48%. A quarter ago, it was expected that this maker of the Jaws of Life device and other engineered products would post earnings of $1.78 per share when it actually produced earnings of $2, delivering a surprise of +12.36%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Idex, which belongs to the Zacks Manufacturing - General Industrial industry, posted revenues of $920.6 million for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 2.01%. This compares to year-ago revenues of $865.4 million. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Idex shares have added about 26.3% since the beginning of the year versus the S&P 500's gain of 8.5%.
What's Next for Idex?While Idex has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Idex was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $2.19 on $904.08 million in revenues for the coming quarter and $8.49 on $3.62 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Manufacturing - General Industrial is currently in the top 21% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Another stock from the same industry, Helios Technologies (HLIO - Free Report) , has yet to report results for the quarter ended June 2026. The results are expected to be released on August 10.
This maker of screw-in hydraulic cartridge valves and manifolds is expected to post quarterly earnings of $0.80 per share in its upcoming report, which represents a year-over-year change of +35.6%. The consensus EPS estimate for the quarter has been revised 4.1% higher over the last 30 days to the current level.
Helios Technologies' revenues are expected to be $230.36 million, up 8.4% from the year-ago quarter.
Key Takeaways IDEX is expected to report Q2 revenues of $902.4 million and adjusted EPS of $2.10 on July 29.IEX may benefit from pharma, semiconductor and data center demand, plus contributions from acquisitions.IDEX faces pressure from higher operating costs and weaker Fire & Safety/Diversified Products performance. IDEX Corporation (IEX - Free Report) is scheduled to release second-quarter 2026 results on July 29, before market open.
The Zacks Consensus Estimate for second-quarter earnings has decreased a penny in the past 60 days. The company has an impressive earnings surprise history, having outperformed the consensus estimate in each of the preceding four quarters, the average surprise being 6%.
The consensus estimate for revenues is pegged at $902.4 million, indicating an increase of 4.3% from the prior-year quarter’s figure. The consensus estimate for adjusted earnings is pinned at $2.10 per share, indicating an increase of 1.5% from the year-ago quarter’s number.
Let's see how things have shaped up for IDEX this earnings season.
Factors to Note Ahead of IDEX’s ResultsThe Health & Science Technologies (HST) segment is expected to have benefited from an increase in volumes, driven by strength in the pharma market and AI-led growth in data center power and semiconductor markets. Also, strength in the space and defense markets is expected to have aided the segment’s performance in the second quarter. The consensus estimate for the HST segment’s revenues is pegged at $407 million, indicating an increase of 11.5% year over year.
An increase in demand for products across the municipal water end market is expected to have aided the Fluid & Metering Technologies (FMT) segment. Higher demand for mining application solutions business is likely to have been a tailwind as well. The consensus estimate for the FMT segment’s revenues is pegged at $314 million, indicating growth of 0.9% year over year.
IDEX has remained focused on expanding its product offerings and market presence through buyouts, which is expected to have boosted its top line. In July 2025, the company acquired Micro-LAM, Inc. (Micro-LAM), which expanded IDEX’s optics technologies offerings. Also, the acquisition of Mott Corp. and its subsidiaries (Mott) in September 2024 expanded the company’s expertise in applied materials science technology capabilities across high-value end markets.
However, the Fire & Safety/Diversified Products (FSDP) segment is expected to have put up a weak show due to softness in the dispensing business arising from the unfavorable timing of dispensing projects in emerging markets. The consensus estimate for the segment’s revenues is pegged at $189 million, decreasing 1.6% from the year-ago quarter figure.
The escalating costs and operating expenses, due to increasing employee-related costs and professional services spending, are likely to have weighed on IEX’s bottom line in the to-be-reported quarter.
Earnings WhisperOur proven model does not conclusively predict an earnings beat for IEX this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is not the case here, as elaborated below.
Earnings ESP: IEX has an Earnings ESP of -0.67% as the Zacks Consensus Estimate is pegged at $2.10 per share, higher than the Most Accurate Estimate of $2.09. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.
Zacks Rank: IEX presently carries a Zacks Rank of 3.
You can see the complete list of today’s Zacks #1 Rank stocks here.
Stocks to ConsiderHere are some companies, which according to our model, have the right combination of elements to beat on earnings in this reporting cycle.
Crane Company (CR - Free Report) has an Earnings ESP of +4.73% and a Zacks Rank of 2 at present. The company is scheduled to release second-quarter 2026 results on July 28.
Crane’s earnings surpassed the Zacks Consensus Estimate in each of the preceding four quarters, the average surprise being 11.3%.
Ferguson Enterprises Inc. (FERG - Free Report) has an Earnings ESP of +1.22% and a Zacks Rank of 2 at present. The company is slated to release second-quarter 2026 results on Aug. 10.
Ferguson’s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 6.5%.
Ingersoll Rand Inc. (IR - Free Report) has an Earnings ESP of +0.61% and a Zacks Rank of 3 at present. The company is slated to release second-quarter 2026 results on July 30.
Ingersoll Rand’s earnings surpassed the Zacks Consensus Estimate in two of the trailing four quarters and matched the mark in two, the average surprise being 2.4%.
Shares of IDEX Corporation (NYSE:IEX – Get Free Report) have earned an average rating of “Moderate Buy” from the nine ratings firms that are presently covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $244.00.
A number of analysts have commented on IEX shares. Seaport Research Partners reissued a “buy” rating and issued a $250.00 target price on shares of IDEX in a report on Tuesday, May 5th. Stifel Nicolaus upped their price target on IDEX from $250.00 to $257.00 and gave the company a “buy” rating in a report on Monday, July 20th. TD Cowen increased their price objective on IDEX from $250.00 to $260.00 and gave the company a “buy” rating in a research report on Thursday, April 30th. Robert W. Baird set a $257.00 price objective on IDEX in a report on Thursday, April 30th. Finally, Weiss Ratings raised IDEX from a “hold (c)” rating to a “hold (c+)” rating in a research report on Wednesday, June 24th.
Check Out Our Latest Research Report on IDEX
IDEX Trading Up 0.4% NYSE:IEX opened at $223.13 on Thursday. The company’s 50 day moving average price is $219.14 and its 200-day moving average price is $206.95. IDEX has a 52 week low of $157.25 and a 52 week high of $231.70. The company has a quick ratio of 2.40, a current ratio of 3.39 and a debt-to-equity ratio of 0.46. The stock has a market cap of $16.51 billion, a price-to-earnings ratio of 33.01, a PEG ratio of 2.19 and a beta of 0.98.
IDEX (NYSE:IEX – Get Free Report) last announced its quarterly earnings results on Wednesday, April 29th. The industrial products company reported $2.00 earnings per share for the quarter, beating the consensus estimate of $1.78 by $0.22. The company had revenue of $886.90 million during the quarter, compared to the consensus estimate of $845.58 million. IDEX had a net margin of 14.38% and a return on equity of 15.29%. The firm’s quarterly revenue was up 8.9% compared to the same quarter last year. During the same quarter last year, the firm earned $1.75 earnings per share. IDEX has set its Q2 2026 guidance at 2.070-2.120 EPS and its FY 2026 guidance at 8.350-8.550 EPS. On average, equities research analysts forecast that IDEX will post 8.48 earnings per share for the current fiscal year.
IDEX Announces Dividend The business also recently declared a quarterly dividend, which was paid on Friday, July 24th. Stockholders of record on Monday, July 6th were paid a $0.73 dividend. The ex-dividend date was Monday, July 6th. This represents a $2.92 dividend on an annualized basis and a dividend yield of 1.3%. IDEX’s payout ratio is currently 43.20%.
Insider Buying and Selling at IDEX In other news, CEO Eric D. Ashleman sold 15,385 shares of the business’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $215.22, for a total transaction of $3,311,159.70. Following the completion of the transaction, the chief executive officer directly owned 66,658 shares of the company’s stock, valued at $14,346,134.76. The trade was a 18.75% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.50% of the stock is owned by insiders.
Institutional Investors Weigh In On IDEX A number of large investors have recently added to or reduced their stakes in the stock. Laurel Wealth Advisors LLC purchased a new position in shares of IDEX in the 4th quarter worth $27,000. Optiver Holding B.V. purchased a new stake in IDEX during the first quarter valued at $27,000. SJS Investment Consulting Inc. increased its position in IDEX by 104.1% during the first quarter. SJS Investment Consulting Inc. now owns 149 shares of the industrial products company’s stock valued at $28,000 after acquiring an additional 76 shares during the last quarter. Cromwell Holdings LLC lifted its holdings in IDEX by 41.1% in the fourth quarter. Cromwell Holdings LLC now owns 199 shares of the industrial products company’s stock valued at $35,000 after acquiring an additional 58 shares during the period. Finally, CYBER HORNET ETFs LLC bought a new position in IDEX in the second quarter valued at about $35,000. Institutional investors own 97.96% of the company’s stock.
About IDEX (Get Free Report)
IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.
Operations at IDEX are organized into three principal segments.
Featured Stories Five stocks we like better than IDEX Telecom Earnings Reveal a Sector That Finally Looks Healthier Defense Earnings Show Readiness Now and Modernization Ahead Why Palantir Investors Aren’t Panicking While the Rest of AI Sells Off MarketBeat Week in Review – 07/20- 07/24
Receive News & Ratings for IDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEX and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEHead to Head Review: Welsbach Technology Metals Acquisition (NASDAQ:EMAT) vs. Captivision (NASDAQ:CAPTW)
NEXT HEADLINE »Head to Head Analysis: Astrotech (NASDAQ:ASTC) & Bae Systems (OTCMKTS:BAESY)
The market expects Idex (IEX - Free Report) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.
The earnings report, which is expected to be released on July 29, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.
Zacks Consensus EstimateThis maker of the Jaws of Life device and other engineered products is expected to post quarterly earnings of $2.10 per share in its upcoming report, which represents a year-over-year change of +1.5%.
Revenues are expected to be $902.43 million, up 4.3% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.08% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Idex?For Idex, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -0.67%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination makes it difficult to conclusively predict that Idex will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Idex would post earnings of $1.78 per share when it actually produced earnings of $2.00, delivering a surprise of +12.36%.
Over the last four quarters, the company has beaten consensus EPS estimates four times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Idex doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Expected Results of an Industry PlayerAnother stock from the Zacks Manufacturing - General Industrial industry, Crane (CR - Free Report) , is soon expected to post earnings of $1.66 per share for the quarter ended June 2026. This estimate indicates a year-over-year change of +11.4%. Revenues for the quarter are expected to be $706.06 million, up 22.3% from the year-ago quarter.
The consensus EPS estimate for Crane has been revised 0.8% higher over the last 30 days to the current level. However, a higher Most Accurate Estimate has resulted in an Earnings ESP of +4.73%.
This Earnings ESP, combined with its Zacks Rank #2 (Buy), suggests that Crane will most likely beat the consensus EPS estimate. The company beat consensus EPS estimates in each of the trailing four quarters.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
California Public Employees Retirement System cut its holdings in shares of IDEX Corporation (NYSE:IEX – Free Report) by 6.7% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 154,528 shares of the industrial products company’s stock after selling 11,067 shares during the quarter. California Public Employees Retirement System owned about 0.21% of IDEX worth $29,291,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also recently added to or reduced their stakes in the business. SJS Investment Consulting Inc. lifted its holdings in shares of IDEX by 104.1% during the 1st quarter. SJS Investment Consulting Inc. now owns 149 shares of the industrial products company’s stock worth $28,000 after acquiring an additional 76 shares during the period. Laurel Wealth Advisors LLC acquired a new stake in shares of IDEX in the fourth quarter worth approximately $27,000. CYBER HORNET ETFs LLC purchased a new stake in IDEX in the second quarter valued at approximately $35,000. Cromwell Holdings LLC grew its holdings in IDEX by 41.1% in the fourth quarter. Cromwell Holdings LLC now owns 199 shares of the industrial products company’s stock valued at $35,000 after purchasing an additional 58 shares during the period. Finally, Root Financial Partners LLC increased its position in IDEX by 57.6% during the first quarter. Root Financial Partners LLC now owns 208 shares of the industrial products company’s stock worth $39,000 after purchasing an additional 76 shares during the last quarter. 97.96% of the stock is owned by institutional investors and hedge funds.
Insiders Place Their Bets In related news, CEO Eric D. Ashleman sold 15,385 shares of the company’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $215.22, for a total transaction of $3,311,159.70. Following the completion of the sale, the chief executive officer directly owned 66,658 shares of the company’s stock, valued at approximately $14,346,134.76. This represents a 18.75% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.50% of the company’s stock.
IDEX Stock Down 0.0% IEX opened at $221.22 on Wednesday. The firm has a 50 day moving average price of $218.40 and a 200 day moving average price of $206.22. The company has a market cap of $16.37 billion, a PE ratio of 32.73, a price-to-earnings-growth ratio of 2.17 and a beta of 0.98. IDEX Corporation has a 1 year low of $157.25 and a 1 year high of $231.70. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.40 and a current ratio of 3.39.
IDEX (NYSE:IEX – Get Free Report) last announced its quarterly earnings results on Wednesday, April 29th. The industrial products company reported $2.00 earnings per share for the quarter, beating analysts’ consensus estimates of $1.78 by $0.22. IDEX had a net margin of 14.38% and a return on equity of 15.29%. The firm had revenue of $886.90 million for the quarter, compared to analysts’ expectations of $845.58 million. During the same period in the previous year, the company posted $1.75 earnings per share. IDEX’s revenue was up 8.9% compared to the same quarter last year. IDEX has set its Q2 2026 guidance at 2.070-2.120 EPS and its FY 2026 guidance at 8.350-8.550 EPS. Sell-side analysts expect that IDEX Corporation will post 8.49 earnings per share for the current year.
IDEX Announces Dividend The firm also recently announced a quarterly dividend, which will be paid on Friday, July 24th. Investors of record on Monday, July 6th will be issued a dividend of $0.73 per share. The ex-dividend date is Monday, July 6th. This represents a $2.92 annualized dividend and a dividend yield of 1.3%. IDEX’s payout ratio is presently 43.20%.
Analyst Upgrades and Downgrades A number of equities analysts have weighed in on the stock. Stifel Nicolaus increased their price target on shares of IDEX from $250.00 to $257.00 and gave the stock a “buy” rating in a research note on Monday. Oppenheimer boosted their price objective on shares of IDEX from $250.00 to $260.00 and gave the company an “outperform” rating in a research note on Tuesday. TD Cowen upped their price objective on IDEX from $250.00 to $260.00 and gave the stock a “buy” rating in a report on Thursday, April 30th. Citigroup increased their target price on IDEX from $243.00 to $252.00 and gave the stock a “buy” rating in a research report on Thursday, April 30th. Finally, Weiss Ratings upgraded IDEX from a “hold (c)” rating to a “hold (c+)” rating in a report on Wednesday, June 24th. Six equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $244.00.
Read Our Latest Report on IDEX
IDEX Company Profile (Free Report)
IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.
Operations at IDEX are organized into three principal segments.
Featured Stories Five stocks we like better than IDEX Confidence Is Back, But Earnings Show the Consumer Is Being Picky AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative? 3 Photonics Companies Making Quantum Tech Possible
Receive News & Ratings for IDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEX and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEClifford Swan Investment Counsel LLC Sells 22,065 Shares of Alphabet Inc. $GOOG
NEXT HEADLINE »California Public Employees Retirement System Purchases 25,620 Shares of Neurocrine Biosciences, Inc. $NBIX
Bank of New York Mellon Corp cut its holdings in IDEX Corporation (NYSE:IEX – Free Report) by 16.7% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 406,486 shares of the industrial products company’s stock after selling 81,622 shares during the quarter. Bank of New York Mellon Corp owned approximately 0.55% of IDEX worth $77,050,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds also recently bought and sold shares of the business. Primecap Management Co. CA increased its position in shares of IDEX by 86.5% during the fourth quarter. Primecap Management Co. CA now owns 3,226,787 shares of the industrial products company’s stock valued at $574,174,000 after buying an additional 1,496,207 shares during the period. Dodge & Cox boosted its position in IDEX by 266.7% during the 4th quarter. Dodge & Cox now owns 1,262,550 shares of the industrial products company’s stock valued at $224,658,000 after acquiring an additional 918,208 shares in the last quarter. Norges Bank bought a new stake in IDEX during the 4th quarter valued at approximately $162,788,000. Millennium Management LLC grew its holdings in shares of IDEX by 293.6% during the 4th quarter. Millennium Management LLC now owns 1,063,763 shares of the industrial products company’s stock worth $189,286,000 after acquiring an additional 793,530 shares during the period. Finally, Balyasny Asset Management L.P. raised its position in shares of IDEX by 35,817.3% in the 4th quarter. Balyasny Asset Management L.P. now owns 720,142 shares of the industrial products company’s stock worth $128,142,000 after acquiring an additional 718,137 shares in the last quarter. Hedge funds and other institutional investors own 97.96% of the company’s stock.
Insider Activity at IDEX In other IDEX news, CEO Eric D. Ashleman sold 15,385 shares of the business’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $215.22, for a total value of $3,311,159.70. Following the sale, the chief executive officer owned 66,658 shares in the company, valued at $14,346,134.76. The trade was a 18.75% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.50% of the company’s stock.
Analysts Set New Price Targets Several brokerages recently weighed in on IEX. BMO Capital Markets started coverage on IDEX in a research note on Friday, March 27th. They issued a “market perform” rating and a $214.00 price target on the stock. Oppenheimer boosted their target price on shares of IDEX from $250.00 to $260.00 and gave the company an “outperform” rating in a report on Tuesday. Robert W. Baird set a $257.00 target price on shares of IDEX in a research report on Thursday, April 30th. Weiss Ratings upgraded shares of IDEX from a “hold (c)” rating to a “hold (c+)” rating in a research note on Wednesday, June 24th. Finally, Stifel Nicolaus lifted their price target on shares of IDEX from $250.00 to $257.00 and gave the company a “buy” rating in a research report on Monday. Six equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, IDEX currently has an average rating of “Moderate Buy” and a consensus target price of $244.00.
Read Our Latest Analysis on IEX
IDEX Stock Performance Shares of IEX stock opened at $221.22 on Wednesday. The company has a quick ratio of 2.40, a current ratio of 3.39 and a debt-to-equity ratio of 0.46. The company has a 50 day moving average price of $218.40 and a 200-day moving average price of $206.22. IDEX Corporation has a 52 week low of $157.25 and a 52 week high of $231.70. The firm has a market capitalization of $16.37 billion, a PE ratio of 32.73, a P/E/G ratio of 2.17 and a beta of 0.98.
IDEX (NYSE:IEX – Get Free Report) last announced its earnings results on Wednesday, April 29th. The industrial products company reported $2.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.78 by $0.22. IDEX had a return on equity of 15.29% and a net margin of 14.38%.The business had revenue of $886.90 million for the quarter, compared to analysts’ expectations of $845.58 million. During the same period last year, the firm posted $1.75 earnings per share. The business’s revenue for the quarter was up 8.9% on a year-over-year basis. IDEX has set its Q2 2026 guidance at 2.070-2.120 EPS and its FY 2026 guidance at 8.350-8.550 EPS. As a group, equities research analysts expect that IDEX Corporation will post 8.49 earnings per share for the current year.
IDEX Announces Dividend The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 24th. Stockholders of record on Monday, July 6th will be given a dividend of $0.73 per share. The ex-dividend date is Monday, July 6th. This represents a $2.92 annualized dividend and a dividend yield of 1.3%. IDEX’s dividend payout ratio (DPR) is presently 43.20%.
About IDEX (Free Report)
IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.
Operations at IDEX are organized into three principal segments.
Featured Articles Five stocks we like better than IDEX Confidence Is Back, But Earnings Show the Consumer Is Being Picky AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative? 3 Photonics Companies Making Quantum Tech Possible Want to see what other hedge funds are holding IEX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IDEX Corporation (NYSE:IEX – Free Report).
Receive News & Ratings for IDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEX and related companies with MarketBeat.com's FREE daily email newsletter.
Fifth Third Bancorp grew its position in IDEX Corporation (NYSE:IEX – Free Report) by 400.1% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 15,849 shares of the industrial products company’s stock after acquiring an additional 12,680 shares during the quarter. Fifth Third Bancorp’s holdings in IDEX were worth $3,004,000 as of its most recent SEC filing.
Several other institutional investors also recently modified their holdings of IEX. SJS Investment Consulting Inc. lifted its position in IDEX by 104.1% in the first quarter. SJS Investment Consulting Inc. now owns 149 shares of the industrial products company’s stock worth $28,000 after purchasing an additional 76 shares during the period. Laurel Wealth Advisors LLC acquired a new position in shares of IDEX in the 4th quarter valued at $27,000. CYBER HORNET ETFs LLC bought a new position in shares of IDEX during the 2nd quarter worth about $35,000. Cromwell Holdings LLC lifted its holdings in shares of IDEX by 41.1% during the 4th quarter. Cromwell Holdings LLC now owns 199 shares of the industrial products company’s stock worth $35,000 after acquiring an additional 58 shares during the period. Finally, Root Financial Partners LLC boosted its position in shares of IDEX by 57.6% during the 1st quarter. Root Financial Partners LLC now owns 208 shares of the industrial products company’s stock valued at $39,000 after acquiring an additional 76 shares in the last quarter. Institutional investors and hedge funds own 97.96% of the company’s stock.
Insider Activity In related news, CEO Eric D. Ashleman sold 15,385 shares of the company’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $215.22, for a total transaction of $3,311,159.70. Following the transaction, the chief executive officer owned 66,658 shares in the company, valued at $14,346,134.76. This represents a 18.75% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.50% of the stock is owned by corporate insiders.
IDEX Stock Performance NYSE:IEX opened at $221.09 on Tuesday. The stock has a market capitalization of $16.36 billion, a P/E ratio of 32.71, a price-to-earnings-growth ratio of 2.21 and a beta of 0.98. The company has a current ratio of 3.39, a quick ratio of 2.40 and a debt-to-equity ratio of 0.46. IDEX Corporation has a 1 year low of $157.25 and a 1 year high of $231.70. The firm has a 50 day moving average of $218.25 and a 200-day moving average of $205.91.
IDEX (NYSE:IEX – Get Free Report) last released its quarterly earnings results on Wednesday, April 29th. The industrial products company reported $2.00 earnings per share for the quarter, beating analysts’ consensus estimates of $1.78 by $0.22. IDEX had a return on equity of 15.29% and a net margin of 14.38%.The firm had revenue of $886.90 million during the quarter, compared to analysts’ expectations of $845.58 million. During the same period last year, the firm posted $1.75 EPS. The business’s revenue was up 8.9% on a year-over-year basis. IDEX has set its Q2 2026 guidance at 2.070-2.120 EPS and its FY 2026 guidance at 8.350-8.550 EPS. As a group, sell-side analysts anticipate that IDEX Corporation will post 8.49 EPS for the current fiscal year.
IDEX Dividend Announcement The firm also recently announced a quarterly dividend, which will be paid on Friday, July 24th. Stockholders of record on Monday, July 6th will be paid a $0.73 dividend. The ex-dividend date is Monday, July 6th. This represents a $2.92 dividend on an annualized basis and a dividend yield of 1.3%. IDEX’s dividend payout ratio (DPR) is 43.20%.
Analyst Upgrades and Downgrades A number of equities research analysts have weighed in on IEX shares. Stifel Nicolaus lifted their price objective on IDEX from $250.00 to $257.00 and gave the company a “buy” rating in a report on Monday. Royal Bank Of Canada increased their target price on IDEX from $252.00 to $261.00 and gave the stock an “outperform” rating in a report on Thursday. TD Cowen raised their target price on IDEX from $250.00 to $260.00 and gave the stock a “buy” rating in a research report on Thursday, April 30th. Citigroup boosted their price target on IDEX from $243.00 to $252.00 and gave the company a “buy” rating in a research note on Thursday, April 30th. Finally, Weiss Ratings raised IDEX from a “hold (c)” rating to a “hold (c+)” rating in a report on Wednesday, June 24th. Six analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, IDEX currently has a consensus rating of “Moderate Buy” and a consensus price target of $242.89.
Get Our Latest Stock Report on IEX
IDEX Company Profile (Free Report)
IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.
Operations at IDEX are organized into three principal segments.
Featured Stories Five stocks we like better than IDEX The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story
Receive News & Ratings for IDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEX and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEDICK’S Sporting Goods, Inc. $DKS Shares Sold by Bank of New York Mellon Corp
NEXT HEADLINE »Bank of New York Mellon Corp Reduces Stock Holdings in Expeditors International of Washington, Inc. $EXPD
For those looking to find strong Industrial Products stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Idex (IEX - Free Report) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.
Idex is one of 187 individual stocks in the Industrial Products sector. Collectively, these companies sit at #6 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Idex is currently sporting a Zacks Rank of #2 (Buy).
Over the past three months, the Zacks Consensus Estimate for IEX's full-year earnings has moved 3.1% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
Based on the latest available data, IEX has gained about 28.7% so far this year. In comparison, Industrial Products companies have returned an average of 16.9%. This means that Idex is outperforming the sector as a whole this year.
Silgan Holdings (SLGN - Free Report) is another Industrial Products stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 17.4%.
The consensus estimate for Silgan Holdings' current year EPS has increased 1.2% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Breaking things down more, Idex is a member of the Manufacturing - General Industrial industry, which includes 41 individual companies and currently sits at #53 in the Zacks Industry Rank. Stocks in this group have gained about 7.9% so far this year, so IEX is performing better this group in terms of year-to-date returns.
Silgan Holdings, however, belongs to the Containers - Metal and Glass industry. Currently, this 4-stock industry is ranked #102. The industry has moved +15.7% so far this year.
Investors interested in the Industrial Products sector may want to keep a close eye on Idex and Silgan Holdings as they attempt to continue their solid performance.
File Photo: The Bombay Stock Exchange logo is seen under a bull statue at the entrance of their building in Mumbai, India January 30, 2018. Picture taken January 30, 2018. REUTERS/Shailesh... Purchase Licensing Rights, opens new tab Read more
CompaniesJuly 14 (Reuters) - Indian Gas Exchange (IGX) has filed for an initial public offering, draft papers showed on Tuesday, as parent Indian Energy Exchange (IEX) (IIAN.NS), opens new tab looks to pare its stake in the gas trading exchange to comply with regulatory rules.
IEX, which currently owns 47.3% of IGX, will sell up to 16.7 million shares in the offering, reducing its stake to 25% -the regulatory ceiling on ownership of a gas exchange by any shareholder that isn't itself a member of the exchange.
IGX shares are expected to list on the BSE, according to its draft prospectus. The company is not selling new shares in the IPO and will not receive any proceeds.
IGX counts GAIL (GAIL.NS), opens new tab, ONGC (ONGC.NS), opens new tab, Indian Oil (IOC.NS), opens new tab, Adani Total Gas (ADAG.NS), opens new tab, Torrent Gas (TORR.BO), opens new tab and NSE Investments among its other shareholders.
The Noida-based company posted a 36.5% rise in annual profit to 420.2 million rupees ($4.37 million) in fiscal 2026, while revenue grew 25% to 610.1 million rupees.
Axis Capital and Motilal Oswal Investment Advisors are managing the offering.
($1 = 96.2000 Indian rupees)
The Reuters Power Up newsletter provides everything you need to know about the global energy industry. Sign up here.
Reporting by Bipasha Dey in Bengaluru; Editing by Shailesh Kuber
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Investors might want to bet on Idex (IEX - Free Report) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.
The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.
Individual investors often find it hard to make decisions based on rating upgrades by Wall Street analysts, since these are mostly driven by subjective factors that are hard to see and measure in real time. In these situations, the Zacks rating system comes in handy because of the power of a changing earnings picture in determining near-term stock price movements.
As such, the Zacks rating upgrade for Idex is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price.
Most Powerful Force Impacting Stock PricesThe change in a company's future earnings potential, as reflected in earnings estimate revisions, has proven to be strongly correlated with the near-term price movement of its stock. The influence of institutional investors has a partial contribution to this relationship, as these big professionals use earnings and earnings estimates to calculate the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their transaction of large amounts of shares then leads to price movement for the stock.
Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for Idex imply an improvement in the company's underlying business. Investors should show their appreciation for this improving business trend by pushing the stock higher.
Harnessing the Power of Earnings Estimate RevisionsEmpirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, so it could be truly rewarding if such revisions are tracked for making an investment decision. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>> .
Earnings Estimate Revisions for IdexFor the fiscal year ending December 2026, this maker of the Jaws of Life device and other engineered products is expected to earn $8.49 per share, which is unchanged compared with the year-ago reported number.
Analysts have been steadily raising their estimates for Idex. Over the past three months, the Zacks Consensus Estimate for the company has increased 2.9%.
Bottom LineUnlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of "buy" and "sell" ratings for its entire universe of more than 4,000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a "Strong Buy" rating and the next 15% get a "Buy" rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.
You can learn more about the Zacks Rank here >>>
The upgrade of Idex to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
Investors interested in Industrial Products stocks should always be looking to find the best-performing companies in the group. Idex (IEX - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.
Idex is one of 188 individual stocks in the Industrial Products sector. Collectively, these companies sit at #11 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Idex is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for IEX's full-year earnings has moved 3% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
Based on the latest available data, IEX has gained about 27.5% so far this year. Meanwhile, the Industrial Products sector has returned an average of 25.5% on a year-to-date basis. This shows that Idex is outperforming its peers so far this year.
Another stock in the Industrial Products sector, Watts Water (WTS - Free Report) , has outperformed the sector so far this year. The stock's year-to-date return is 41.8%.
For Watts Water, the consensus EPS estimate for the current year has increased 1.7% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Idex belongs to the Manufacturing - General Industrial industry, which includes 42 individual stocks and currently sits at #90 in the Zacks Industry Rank. This group has gained an average of 13.1% so far this year, so IEX is performing better in this area. Watts Water is also part of the same industry.
Going forward, investors interested in Industrial Products stocks should continue to pay close attention to Idex and Watts Water as they could maintain their solid performance.
NORTHBROOK, Ill.--(BUSINESS WIRE)--IDEX Corporation (NYSE:IEX) announced today that it will release its second quarter 2026 results on Wednesday, July 29, 2026, prior to market open. An investor conference call and webcast will take place at 8:00 a.m. (CT) that same day with Chief Executive Officer and President Eric Ashleman and Senior Vice President and Chief Financial Officer Sean Gillen. The event and associated earnings presentation will be available via webcast in listen-only mode on the C.
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.
Even though momentum is a popular stock characteristic, it can be tough to define. Debate surrounding which are the best and worst metrics to focus on is lengthy, but the Zacks Momentum Style Score, part of the Zacks Style Scores, helps address this issue for us.
Below, we take a look at Idex (IEX - Free Report) , which currently has a Momentum Style Score of B. We also discuss some of the main drivers of the Momentum Style Score, like price change and earnings estimate revisions.
It's also important to note that Style Scores work as a complement to the Zacks Rank, our stock rating system that has an impressive track record of outperformance. Idex currently has a Zacks Rank of #2 (Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of "A or B" outperform the market over the following one-month period.
You can see the current list of Zacks #1 Rank Stocks here >>>
Set to Beat the Market?Let's discuss some of the components of the Momentum Style Score for IEX that show why this maker of the Jaws of Life device and other engineered products shows promise as a solid momentum pick.
A good momentum benchmark for a stock is to look at its short-term price activity, as this can reflect both current interest and if buyers or sellers currently have the upper hand. It is also useful to compare a security to its industry, as this can help investors pinpoint the top companies in a particular area.
For IEX, shares are up 2.95% over the past week while the Zacks Manufacturing - General Industrial industry is up 3.58% over the same time period. Shares are looking quite well from a longer time frame too, as the monthly price change of 7.74% compares favorably with the industry's 4.46% performance as well.
Considering longer term price metrics, like performance over the last three months or year, can be advantageous as well. Shares of Idex have increased 20.57% over the past quarter, and have gained 29.91% in the last year. In comparison, the S&P 500 has only moved 13.8% and 26.67%, respectively.
Investors should also take note of IEX's average 20-day trading volume. Volume is a useful item in many ways, and the 20-day average establishes a good price-to-volume baseline; a rising stock with above average volume is generally a bullish sign, whereas a declining stock on above average volume is typically bearish. Right now IEX is averaging 687,238 shares for the last 20 days..
Earnings OutlookThe Zacks Momentum Style Score encompasses many things, including estimate revisions and a stock's price movement. Investors should note that earnings estimates are also significant to the Zacks Rank, and a nice path here can be promising. We have recently been noticing this with IEX.
Over the past two months, 9 earnings estimates moved higher compared to none lower for the full year. These revisions helped boost IEX's consensus estimate, increasing from $8.24 to $8.49 in the past 60 days. Looking at the next fiscal year, 9 estimates have moved upwards while there have been no downward revisions in the same time period.
Bottom LineTaking into account all of these elements, it should come as no surprise that IEX is a #2 (Buy) stock with a Momentum Score of B. If you've been searching for a fresh pick that's set to rise in the near-term, make sure to keep Idex on your short list.
NORTHBROOK, Ill.--(BUSINESS WIRE)--IDEX CORPORATION (NYSE:IEX) today announced that its Board of Directors has approved a regular quarterly cash dividend of $0.73 per common share. This dividend will be paid July 24, 2026 to shareholders of record as of July 6, 2026. This dividend represents the company’s 127th consecutive regular quarterly cash dividend payment.
IDEX Corp. (NYSE:IEX) announces a regular quarterly cash dividend of $0.73 per common share, its 127th consecutive such payment.
Share About IDEX
IDEX Corporation (NYSE: IEX), a global engineered products company, is comprised of three primary business segments – Health & Science Technologies, Fluid & Metering Technologies, and Fire & Safety / Diversified Products. Thousands of IDEX employees around the world design and manufacture highly engineered components and applied solutions that are vital to the advances of modern life and help IDEX live its purpose – Trusted Solutions, Improving Lives™. From satellite communications to water systems, from medical diagnostic components to emergency rescue tools and more, we collaborate with customers in the most critical industries to develop solutions that make the world better today and into the future. Founded in 1988, IDEX now includes more than 50 dynamic businesses around the world and manufacturing operations in more than 20 countries. Learn more about the impactful work we do at www.idexcorp.com.
Boothbay Fund Management LLC grew its position in shares of IDEX Corporation (NYSE: IEX) by 1,165.6% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 30,247 shares of the industrial products company's stock after buying an additional 27,857 shares during the
Shares of IDEX Corporation (NYSE: IEX - Get Free Report) have received an average recommendation of "Moderate Buy" from the eight ratings firms that are presently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 12
NORTHBROOK, Ill.--(BUSINESS WIRE)--IDEX Corporation (NYSE:IEX) announced today that it will release its first quarter 2026 results on Wednesday, April 29, 2026, prior to market open. An investor conference call and webcast will take place at 8:00 a.m. (CT) that same day with Chief Executive Officer and President Eric Ashleman and Senior Vice President and Chief Financial Officer Sean Gillen. The event and associated earnings presentation will be available via webcast in listen-only mode on the Company's Investor Relations site at https://investors.idexcorp.com. To participate via telephone, please dial 888-596-4144 and use confirmation code 2518354. Telephone participants are asked to connect five minutes prior to the start of the conference call. A replay of the earnings call will be available via webcast on the Company's website.
About IDEX
IDEX Corporation (NYSE: IEX), a global engineered products company, is comprised of three primary business segments – Health & Science Technologies, Fluid & Metering Technologies, and Fire & Safety / Diversified Products. Thousands of IDEX employees around the world design and manufacture highly engineered components and applied solutions that are vital to the advances of modern life and help IDEX live its purpose – Trusted Solutions, Improving Lives™. From satellite communications to water systems, from medical diagnostic components to emergency rescue tools and more, we collaborate with customers in the most critical industries to develop solutions that make the world better today and into the future. Founded in 1988, IDEX now includes more than 50 dynamic businesses around the world and manufacturing operations in more than 20 countries. Learn more about the impactful work we do at www.idexcorp.com.
IDEX (NYSE:IEX – Get Free Report) and DNOW (NYSE:DNOW – Get Free Report) are both industrials companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation.
Profitability This table compares IDEX and DNOW’s net margins, return on equity and return on assets.
Net Margins Return on Equity Return on Assets IDEX 13.98% 15.03% 8.70% DNOW -2.66% 7.26% 4.68% Analyst Ratings This is a breakdown of recent recommendations for IDEX and DNOW, as reported by MarketBeat.
Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IDEX 0 3 6 0 2.67 DNOW 2 0 2 0 2.00 IDEX currently has a consensus price target of $226.80, suggesting a potential upside of 19.19%. DNOW has a consensus price target of $17.00, suggesting a potential upside of 40.67%. Given DNOW’s higher possible upside, analysts plainly believe DNOW is more favorable than IDEX.
Institutional and Insider Ownership 98.0% of IDEX shares are held by institutional investors. Comparatively, 97.6% of DNOW shares are held by institutional investors. 0.5% of IDEX shares are held by company insiders. Comparatively, 2.7% of DNOW shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Valuation & Earnings This table compares IDEX and DNOW”s top-line revenue, earnings per share (EPS) and valuation.
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IDEX $3.46 billion 4.09 $483.20 million $6.41 29.68 DNOW $2.82 billion 0.80 -$89.00 million ($0.29) -41.67 IDEX has higher revenue and earnings than DNOW. DNOW is trading at a lower price-to-earnings ratio than IDEX, indicating that it is currently the more affordable of the two stocks.
Risk and Volatility IDEX has a beta of 0.99, indicating that its stock price is 1% less volatile than the S&P 500. Comparatively, DNOW has a beta of 0.79, indicating that its stock price is 21% less volatile than the S&P 500.
Summary IDEX beats DNOW on 12 of the 14 factors compared between the two stocks.
About IDEX (Get Free Report)
IDEX Corporation, together with its subsidiaries, provides applied solutions worldwide. The company operates through three segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT segment designs, produces, and distributes positive displacement pumps, valves, small volume provers, flow meters, injectors, and other fluid-handling pump modules and systems, as well as flow monitoring and other services for the food, chemical, general industrial, water and wastewater, agricultural, and energy industries. The HST segment designs, produces, and distributes precision fluidics positive displacement pumps, powder and liquid processing technologies, drying systems, micro-precision components, pneumatic components and sealing solutions, high performance molded and extruded sealing components, custom mechanical and shaft seals, engineered hygienic mixers and valves, biocompatible medical devices and implantables, air compressors and blowers, optical components and coatings, laboratory and commercial equipment, and precision photonic solutions. This segment serves food and beverage, life sciences, analytical instruments, pharmaceutical and biopharmaceutical, industrial, semiconductor, automotive/transportation, medical/dental, energy, cosmetics, marine, chemical, wastewater and water treatment, research and aerospace/defense markets. The FSDP segment designs, produces, and distributes firefighting pumps, valves and controls, rescue tools, lifting bags, and other components and systems for the fire and rescue industry; engineered stainless steel banding and clamping devices for various industrial and commercial applications; and precision equipment for dispensing, metering, and mixing colorants and paints used in retail and commercial businesses. IDEX Corporation was incorporated in 1987 and is headquartered in Northbrook, Illinois.
About DNOW (Get Free Report)
DNOW Inc. distributes downstream energy and industrial products for petroleum refining, chemical processing, LNG terminals, power generation utilities, and customer on-site locations in the United States, Canada, and internationally. The company provides consumable maintenance, repair, and operating supplies; pipes, manual and automated valves, fittings, flanges, gaskets, fasteners, electrical instrumentations, artificial lift, pumping solutions, valve actuation and modular process, and measurement and control equipment; and mill supplies, tools, safety supplies, and personal protective equipment, as well as artificial lift systems, coatings, and miscellaneous expendable items. It also offers original equipment manufacturer equipment, including pumps, generator sets, air compressors, dryers, blowers, mixers, and valves; modular oil and gas tank battery solutions; and application systems, work processes, parts integration, optimization solutions, and after-sales support services. In addition, the company provides supply chain and materials management; inventory planning and management, procurement, and warehouse management, as well as solutions for logistics, point of issue technology, project management, business process, and performance metrics reporting services. It serves customers in the upstream, midstream, and downstream sectors of the energy industry, including drilling contractors, well-servicing companies, independent and national oil and gas companies, midstream operators, and refineries, as well as petrochemical, chemical, utilities, RNG facilities, and other downstream energy processors; and industrial and manufacturing companies. The company was formerly known as NOW Inc. and changed its name to DNOW Inc. in January 2024. DNOW Inc. was founded in 1862 and is headquartered in Houston, Texas.
Receive News & Ratings for IDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEX and related companies with MarketBeat.com's FREE daily email newsletter.
, /PRNewswire/ -- Mott Corporation will now offer deltaVision's high‑performance valve and fluid control solutions to North American spacecraft manufacturers, expanding access to propulsion feed‑system components engineered for reliability, cleanliness, and mission assurance. Delivered through a formal partnership with deltaVision, the offering provides customers with significantly shorter lead times for mission‑critical propulsion components.
Mott and deltaVision Partner to Advance Spacecraft Propulsion Flow Control Systems By combining deltaVision's precision valve technology with Mott's propulsion‑grade filtration, flow restrictors, and integrated flow‑control assemblies, spacecraft programs can source fully integrated, contamination‑controlled propulsion solutions from a coordinated U.S. and European supply chain.
"This partnership allows us to offer some of the best‑performing valves in the market to our North American customers, while streamlining access to a more complete propulsion solution," said Sean Kane, General Manager of Mott's Aerospace & Defense division. "Together, we are supporting propulsion systems that demand the highest standards of reliability, cleanliness, and mission assurance—while helping customers meet aggressive program schedules."
deltaVision echoed the sentiment, emphasizing the value of a coordinated approach to propulsion hardware. "Propulsion systems demand flawless flow control—from the moment propellant leaves the tank to the instant it reaches the thruster. Together with Mott, we're creating a more resilient, more capable supply chain of mission critical components for the U.S. space industry with the shortest lead times in the market," said Alex Plebuch, CEO and Co Founder of deltaVision.
The collaboration will focus on:
Integrated propulsion feed‑system assemblies, combining valves, filters, restrictors, and manifolds Harmonized qualification and testing approaches supporting U.S., EU, and international missions Improved lead times with coordinated, export‑compliant delivery pathways Joint development of next‑generation flow‑control technologies for chemical and electric propulsion As spacecraft programs demand higher performance and scalable manufacturing, the Mott‑deltaVision offering is positioned to support next‑generation space missions operating in extreme thermal, pressure, and corrosive environments.
About deltaVision
deltaVision GmbH is an EN 9100‑certified German aerospace manufacturer specializing in high‑performance valves, fluid‑control systems, and orbital refueling technologies for spacecraft propulsion applications.
About Mott Corporation
For more than 60 years, Mott Corporation has delivered filtration, flow control, and thermal management solutions proven in orbit and trusted in flight. Manufactured in AS9100‑certified facilities in the United States, Mott supports mission‑critical systems across space, defense, and aerospace applications.
Mott Corp. is a unit of IDEX Corporation (NYSE: IEX).
Media Contact: Pooja Saney
Digital Marketing Manager
Mott Corporation
Email: [email protected]
Phone: 860-634-6650
Robeco Institutional Asset Management B.V. cut its holdings in IDEX Corporation (NYSE:IEX – Free Report) by 79.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 1,468 shares of the industrial products company’s stock after selling 5,601 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in IDEX were worth $261,000 at the end of the most recent reporting period.
Several other institutional investors also recently bought and sold shares of the business. Wellington Management Group LLP raised its holdings in IDEX by 3.4% in the 3rd quarter. Wellington Management Group LLP now owns 6,477,929 shares of the industrial products company’s stock valued at $1,054,348,000 after acquiring an additional 211,696 shares during the last quarter. State Street Corp raised its holdings in IDEX by 1.8% in the 3rd quarter. State Street Corp now owns 3,154,742 shares of the industrial products company’s stock valued at $513,466,000 after acquiring an additional 54,990 shares during the last quarter. Nordea Investment Management AB raised its holdings in IDEX by 193.6% in the 3rd quarter. Nordea Investment Management AB now owns 2,364,312 shares of the industrial products company’s stock valued at $382,049,000 after acquiring an additional 1,559,124 shares during the last quarter. Van ECK Associates Corp raised its holdings in IDEX by 8.3% in the 3rd quarter. Van ECK Associates Corp now owns 1,913,157 shares of the industrial products company’s stock valued at $311,385,000 after acquiring an additional 146,618 shares during the last quarter. Finally, Invesco Ltd. raised its holdings in IDEX by 16.1% in the 3rd quarter. Invesco Ltd. now owns 1,809,788 shares of the industrial products company’s stock valued at $294,561,000 after acquiring an additional 250,447 shares during the last quarter. 97.96% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades IEX has been the subject of several analyst reports. Argus upgraded IDEX from a “hold” rating to a “buy” rating and set a $240.00 price target for the company in a report on Friday, February 6th. Robert W. Baird set a $247.00 price target on IDEX in a report on Thursday, February 5th. Stifel Nicolaus cut their price target on IDEX from $244.00 to $241.00 and set a “buy” rating for the company in a report on Tuesday. TD Cowen boosted their price target on IDEX from $200.00 to $250.00 and gave the company a “buy” rating in a report on Thursday, February 5th. Finally, DA Davidson boosted their price target on IDEX from $180.00 to $195.00 and gave the company a “neutral” rating in a report on Thursday, February 5th. Six analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $228.90.
Read Our Latest Stock Report on IEX
IDEX Stock Up 2.5% Shares of NYSE IEX opened at $205.69 on Friday. IDEX Corporation has a 52-week low of $157.25 and a 52-week high of $217.15. The firm has a fifty day moving average of $199.26 and a 200-day moving average of $185.22. The stock has a market capitalization of $15.29 billion, a PE ratio of 32.09, a P/E/G ratio of 2.03 and a beta of 0.99. The company has a quick ratio of 2.02, a current ratio of 2.86 and a debt-to-equity ratio of 0.45.
IDEX (NYSE:IEX – Get Free Report) last announced its quarterly earnings data on Wednesday, February 4th. The industrial products company reported $2.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.04 by $0.06. IDEX had a net margin of 13.98% and a return on equity of 15.03%. The company had revenue of $899.10 million during the quarter, compared to analysts’ expectations of $882.00 million. During the same period in the previous year, the company earned $2.04 EPS. The business’s quarterly revenue was up 4.2% compared to the same quarter last year. IDEX has set its Q1 2026 guidance at 1.730-1.780 EPS and its FY 2026 guidance at 8.150-8.35 EPS. On average, analysts anticipate that IDEX Corporation will post 8.26 EPS for the current year.
IDEX Profile (Free Report)
IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.
Operations at IDEX are organized into three principal segments.
See Also Five stocks we like better than IDEX
Receive News & Ratings for IDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEX and related companies with MarketBeat.com's FREE daily email newsletter.
Idex (IEX - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.
The earnings report, which is expected to be released on April 29, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.
Zacks Consensus EstimateThis maker of the Jaws of Life device and other engineered products is expected to post quarterly earnings of $1.78 per share in its upcoming report, which represents a year-over-year change of +1.7%.
Revenues are expected to be $835.16 million, up 2.6% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.09% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Idex?For Idex, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -0.85%.
On the other hand, the stock currently carries a Zacks Rank of #4.
So, this combination makes it difficult to conclusively predict that Idex will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Idex would post earnings of $2.04 per share when it actually produced earnings of $2.10, delivering a surprise of +2.94%.
Over the last four quarters, the company has beaten consensus EPS estimates four times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Idex doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Expected Results of an Industry PlayerIngersoll Rand (IR - Free Report) , another stock in the Zacks Manufacturing - General Industrial industry, is expected to report earnings per share of $0.74 for the quarter ended March 2026. This estimate points to a year-over-year change of +2.8%. Revenues for the quarter are expected to be $1.83 billion, up 6.4% from the year-ago quarter.
Over the last 30 days, the consensus EPS estimate for Ingersoll has been revised 0.6% down to the current level. Nevertheless, the company now has an Earnings ESP of -0.23%, reflecting a lower Most Accurate Estimate.
This Earnings ESP, combined with its Zacks Rank #3 (Hold), makes it difficult to conclusively predict that Ingersoll will beat the consensus EPS estimate. Over the last four quarters, the company surpassed EPS estimates just once.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
IDEX Corporation has outperformed the S&P 500, with shares up 21.4% since November, driven by rising revenue, profits, and cash flow. IEX remains diversified across industries, with recent growth in Health & Science Technologies fueled by acquisitions and organic gains in semiconductors and aviation. Despite recent gains, IEX appears fairly valued on an absolute basis but trades at a discount relative to peers; a 'hold' rating is maintained.
Cwm LLC raised its position in shares of IDEX Corporation (NYSE:IEX – Free Report) by 144.8% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 14,431 shares of the industrial products company’s stock after purchasing an additional 8,537 shares during the quarter. Cwm LLC’s holdings in IDEX were worth $2,568,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also bought and sold shares of the company. GoalVest Advisory LLC bought a new position in IDEX in the 4th quarter valued at approximately $26,000. UMB Bank n.a. lifted its position in IDEX by 61.0% in the 3rd quarter. UMB Bank n.a. now owns 198 shares of the industrial products company’s stock valued at $32,000 after acquiring an additional 75 shares in the last quarter. CYBER HORNET ETFs LLC bought a new position in IDEX in the 2nd quarter valued at approximately $35,000. Cromwell Holdings LLC increased its holdings in IDEX by 41.1% in the 4th quarter. Cromwell Holdings LLC now owns 199 shares of the industrial products company’s stock worth $35,000 after buying an additional 58 shares in the last quarter. Finally, MUFG Securities EMEA plc bought a new stake in IDEX in the 2nd quarter worth about $39,000. 97.96% of the stock is currently owned by institutional investors.
Analyst Ratings Changes IEX has been the subject of several research analyst reports. DA Davidson lifted their price objective on IDEX from $180.00 to $195.00 and gave the stock a “neutral” rating in a report on Thursday, February 5th. BMO Capital Markets initiated coverage on IDEX in a report on Friday, March 27th. They issued a “market perform” rating and a $214.00 price objective for the company. TD Cowen lifted their price objective on IDEX from $200.00 to $250.00 and gave the stock a “buy” rating in a report on Thursday, February 5th. Stifel Nicolaus cut their price objective on IDEX from $244.00 to $241.00 and set a “buy” rating for the company in a report on Tuesday, April 14th. Finally, Argus upgraded shares of IDEX from a “hold” rating to a “buy” rating and set a $240.00 price objective on the stock in a research note on Friday, February 6th. Six equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, IDEX currently has an average rating of “Moderate Buy” and an average target price of $228.90.
Get Our Latest Stock Report on IEX
IDEX Stock Down 0.8% NYSE IEX opened at $204.89 on Friday. The stock’s 50-day moving average price is $198.76 and its 200-day moving average price is $186.45. The company has a quick ratio of 2.02, a current ratio of 2.86 and a debt-to-equity ratio of 0.45. IDEX Corporation has a 52 week low of $157.25 and a 52 week high of $217.15. The company has a market capitalization of $15.23 billion, a P/E ratio of 31.96, a price-to-earnings-growth ratio of 2.09 and a beta of 0.99.
IDEX (NYSE:IEX – Get Free Report) last posted its quarterly earnings results on Wednesday, February 4th. The industrial products company reported $2.10 earnings per share for the quarter, topping analysts’ consensus estimates of $2.04 by $0.06. The business had revenue of $899.10 million during the quarter, compared to analyst estimates of $882.00 million. IDEX had a net margin of 13.98% and a return on equity of 15.03%. The company’s revenue was up 4.2% on a year-over-year basis. During the same period in the prior year, the business posted $2.04 earnings per share. IDEX has set its Q1 2026 guidance at 1.730-1.780 EPS and its FY 2026 guidance at 8.150-8.35 EPS. On average, equities research analysts predict that IDEX Corporation will post 8.23 earnings per share for the current year.
About IDEX (Free Report)
IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.
Operations at IDEX are organized into three principal segments.
Recommended Stories Five stocks we like better than IDEX Want to see what other hedge funds are holding IEX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IDEX Corporation (NYSE:IEX – Free Report).
Receive News & Ratings for IDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEX and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEFarther Finance Advisors LLC Raises Stock Position in Vanguard Long-Term Corporate Bond ETF $VCLT
NEXT HEADLINE »Cwm LLC Boosts Stock Holdings in SPDR S&P Oil & Gas Equipment & Services ETF $XES
NORTHBROOK, Ill.--(BUSINESS WIRE)--IDEX Corporation (NYSE: IEX) today announced its financial results for the three-month period ended March 31, 2026. “We delivered a strong first quarter, with results ahead of our expectations led by continued momentum in our growth platforms within our Health & Science Technologies segment,” said Eric D. Ashleman, IDEX Corporation Chief Executive Officer and President. “Our first quarter results demonstrate that our strategy is working, with strong execut.
Q1 2026 net sales were $886.9 million. The estimated revenue was $845.57 million.GAAP diluted EPS was $1.61. The estimated EPS was $1.41.Adjusted diluted EPS was $2.00. The estimated EPS was $1.41.Record quarterly orders reached $988.3 million, up 13% year over year.Organic sales rose 5%; adjusted EBITDA margin improved 50 bps to 26.0%.Returned $129 million to shareholders via buybacks and dividends. On April 29, 2026, IDEX Corp IEX released its 8-K filing detailing first-quarter 2026 results. Revenue increased 9% year over year to $886.9 million, supported by 5% organic growth, while GAAP diluted EPS rose 28% to $1.61 and adjusted diluted EPS increased 14% to $2.00. The company reported record orders of $988.3 million, up 13% on a reported basis.
IDEX Corp IEX manufactures pumps, flow meters, valves, and fluidic systems for customers in industrial, fire and safety, life science, and water end markets. Its three segments are fluid and metering technologies, health and science technologies, and fire and safety and diversified products. Based in Lake Forest, Illinois, the company operates manufacturing in over 20 countries with over 7,000 employees. IDEX Corp (IEX) generated $3.5 billion in revenue in 2025.
Quarterly performance vs. expectations Net sales were $886.9 million, which is above the estimated revenue of $845.57 million. GAAP diluted EPS was $1.61, which is above the estimated EPS of $1.41. Adjusted diluted EPS was $2.00, which is above the estimated EPS of $1.41.
Record orders of $988.3 million highlight broad demand across the portfolio. Organic sales grew 5% as strength in Health & Science Technologies (HST) more than offset softer volumes in Fire & Safety/Diversified Products (FSDP) and Fluid & Metering Technologies (FMT). While revenue outperformance matters for an industrial products company because it demonstrates end-market traction and pricing resilience, the mix shift also pressured gross margin by 40 bps to 44.9%.
Management commentary“We delivered a strong first quarter, with results ahead of our expectations led by continued momentum in our growth platforms within our Health & Science Technologies segment,” said Eric D. Ashleman, IDEX Corporation Chief Executive Officer and President.“Our first quarter results demonstrate that our strategy is working, with strong execution across the portfolio and increasing traction in the markets where we are choosing to compete. The application of 8020 continues to sharpen our priorities and reallocate resources toward opportunities with stronger growth and margin profiles.”Financial highlights and why they matter Adjusted EBITDA rose to $230.4 million, and the adjusted EBITDA margin improved 50 bps to 26.0%. For industrial product companies with diverse end-market exposure, stable-to-improving EBITDA margins are critical as they reflect pricing discipline, cost control, and operating leverage amid varied demand conditions.
Net income margin expanded to 13.5% from 11.7%, aided by operational improvement and lower restructuring and impairment expense. Capital deployment remained active, with $76.3 million in share repurchases and $52.8 million in dividends, signaling ongoing commitment to shareholder returns.
IDEX Corp IEX – Consolidated Q1 Results Metric Q1 2026 Q1 2025 Change Orders $988.3M $871.9M +13% Net sales $886.9M $814.3M +9% Organic sales growth +5% — — Gross margin 44.9% 45.3% -40 bps Net income attributable to IDEX $120.0M $95.5M +25% Net income margin 13.5% 11.7% +180 bps Diluted EPS (GAAP) $1.61 $1.26 +28% Adjusted diluted EPS $2.00 $1.75 +14% Adjusted EBITDA $230.4M $208.0M +11% Adjusted EBITDA margin 26.0% 25.5% +50 bps Cash from operations $103.7M $105.7M -$2.0M Free cash flow $86.0M $91.4M -$5.4MSegment trends Health & Science Technologies led growth with net sales up 17% and organic sales up 11%, driven by higher volumes tied to AI-driven demand for data center power and semiconductor markets, and strength in space and defense. Adjusted EBITDA margin improved to 26.6%.
Fluid & Metering Technologies net sales rose 4% and organic sales increased 2%, primarily from positive price. Volumes were mixed by end market, with weakness in chemical and general industrial more than offsetting strength in municipal water, semiconductor, and mining. Adjusted EBITDA margin was 32.7%.
Fire & Safety/Diversified Products net sales increased 2%, while organic sales decreased 1% as higher volumes in Fire & Safety and positive price were offset by lower volumes in Dispensing due to project timing. Adjusted EBITDA margin rose to 29.7%.
Segment Results – Q1 2026 Segment Net Sales 2026 Net Sales 2025 Organic Sales Change Adj. EBITDA Margin Health & Science Technologies $398.4M $341.5M +11% 26.6% Fluid & Metering Technologies $301.5M $290.5M +2% 32.7% Fire & Safety/Diversified Products $188.3M $184.3M -1% 29.7%Cash flow and balance sheet Operating cash flow was $103.7 million, down slightly year over year as higher earnings were offset by the timing of customer payments. Free cash flow was $86.0 million, reflecting higher capital expenditures of $17.7 million. Free cash flow conversion was 58%.
Cash and cash equivalents ended the quarter at $586.2 million. Long-term borrowings were $1,871.8 million, up from $1,820.1 million at year-end. Total shareholders’ equity increased to $4,049.8 million, aided by higher retained earnings, while treasury stock increased due to $76.3 million in share repurchases.
Why the performance and challenges matter For industrial suppliers, order momentum and organic growth are key indicators of demand health. Record orders and 5% organic growth suggest robust activity in areas like data center power and semiconductors. At the same time, a 40 bps gross margin decline underscores the impact of mix and price/cost pressure, which can weigh on profitability if sustained.
Cash generation remains essential for funding innovation, acquisitions, and shareholder returns. Slightly lower operating cash flow and reduced free cash flow conversion reflect working capital timing and higher capital investments, factors worth monitoring alongside margin progression and segment mix.
GuruFocus Valuation Check Based on GuruFocus’s proprietary GF Value, IDEX Corp IEX appears modestly undervalued. The GF Value stands at $221.09 versus a current price of $205.36, indicating the shares are approximately 7.1% undervalued. This suggests a valuation cushion relative to intrinsic value estimates derived from historical multiples, past financial performance, and future business estimates.
The company’s GF Score of 93/100 is strong and reflects a compelling overall investment profile. A Financial Strength score of 7/10 points to a solid balance sheet and funding flexibility. A Profitability Rank of 9/10 and a Growth Rank of 8/10 highlight durable margins and consistent expansion, while a 4-star Predictability rating and a Moat Score of 7/10 suggest relatively steady operations and defensible competitive positions within Industrial Products.
There were no insider transactions in the last three months. A lack of recent insider activity is neutral, as it provides neither a strong bullish signal from insider buying nor a cautionary signal from insider selling. For a deeper dive, visit the IDEX Corp stock page on GuruFocus.
Explore the complete 8-K earnings release (here) from IDEX Corp for further details.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Idex (IEX - Free Report) came out with quarterly earnings of $2 per share, beating the Zacks Consensus Estimate of $1.78 per share. This compares to earnings of $1.75 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +12.68%. A quarter ago, it was expected that this maker of the Jaws of Life device and other engineered products would post earnings of $2.04 per share when it actually produced earnings of $2.1, delivering a surprise of +2.94%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Idex, which belongs to the Zacks Manufacturing - General Industrial industry, posted revenues of $886.9 million for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 6.20%. This compares to year-ago revenues of $814.3 million. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Idex shares have added about 15.4% since the beginning of the year versus the S&P 500's gain of 4.3%.
What's Next for Idex?While Idex has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Idex was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $2.11 on $891.66 million in revenues for the coming quarter and $8.23 on $3.54 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Manufacturing - General Industrial is currently in the bottom 37% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Chart Industries (GTLS - Free Report) , another stock in the same industry, has yet to report results for the quarter ended March 2026.
This equipment maker for the energy sector is expected to post quarterly earnings of $2.16 per share in its upcoming report, which represents a year-over-year change of +16.1%. The consensus EPS estimate for the quarter has been revised 10.9% lower over the last 30 days to the current level.
Chart Industries' revenues are expected to be $1.05 billion, up 4.5% from the year-ago quarter.
Key Takeaways IDEX Q1 EPS rose 14.3% and beat estimates, sales grew 8.9% on strong HST demand.IEX saw robust growth in AI-linked data centers, semiconductors and defense markets.Record orders and raised 2026 guidance reflect improving demand and confidence. IDEX Corporation (IEX - Free Report) delivered first-quarter 2026 adjusted earnings of $2.00 per share, topping the Zacks Consensus Estimate of $1.78 by 12.4%. The metric rose 14.3% year over year. Net sales of $886.9 million beat the consensus mark of $835 million by 6.2% and increased 8.9% from the year-ago quarter.
Results were driven by solid traction in the Health & Science Technologies segment, where higher volumes in AI-linked data center power and semiconductor end markets, along with strength in space and defense, supported growth. IDEX also posted record orders, signaling improving demand early in 2026.
Organic sales increased 5% year over year. While acquisitions/divestitures had a positive impact on sales of 1%, foreign currency translation had a positive impact of 3% on sales.
Segmental DetailsNet sales from the Fluid & Metering Technologies segment totaled $301.5 million, up 4% year over year. Our estimate for segmental net sales was $297.3 million. Organic sales increased 2% year over year. Foreign currency translation had a positive impact of 2% on sales.
Net sales from the Health & Science Technologies segment totaled $398.4 million, up 17% year over year. Organic sales increased 11% year over year. Acquisitions/divestitures and foreign currency translation had a positive impact of 3% each on sales.
Net sales from the Fire & Safety/Diversified Products segment totaled $188.3 million, which increased 2% year over year. Our estimate for segmental net sales was $182 million. Organic sales decreased 1% on a year-over-year basis, while foreign currency translation had a favorable impact of 3% on sales.
IEX’s Orders Signal Broad-Based DemandOrders increased 13% year over year to $988.3 million, with organic orders up 10%. Management pointed to momentum and backlog building in businesses tied to several end markets, particularly AI-driven areas, pharma and space and defense.
IDEX’s Margin ProfileIDEX’s cost of sales increased 9.7% year over year to $488.8 million. The adjusted gross margin was 44.9%, down 40 basis points year over year, reflecting unfavorable mix and higher costs, partially offset by productivity improvements and volume leverage. Selling, general and administrative expenses increased to $218.3 million from $209.4 million in the prior-year period.
Adjusted EBITDA rose 10.8% to $230.4 million and the adjusted EBITDA margin improved 50 basis points to 26%. Operating income increased 21.4% to $172.4 million, aided by stronger operating performance and a lower restructuring and asset impairment burden compared to the prior year period. The operating margin was 19.4%, up 200 bps year over year. Interest expenses (net) were relatively stable year over year at $16 million.
IEX’s Cash Uses Highlight Shareholder ReturnsCash flows from operating activities were $103.7 million compared with $105.7 million a year ago, as increased earnings were offset by customer payment timing. Free cash flow declined 5.9% to $86 million, reflecting both working-capital timing and higher capital expenditures of $17.7 million.
The company continued to return capital, repurchasing $76.3 million of stock and paying $52.8 million in dividends during the quarter. On the balance sheet, cash and cash equivalents were $586.2 million exiting the first quarter, while long-term borrowings (net) stood at $1.87 billion.
IDEX’s Raised 2026 Outlook Reflects ConfidenceManagement raised full-year 2026 guidance, projecting organic sales growth of 3-4% compared with prior expectations of 1-2%. The company also lifted its full-year adjusted earnings outlook to $8.35-$8.55 per share from $8.15-$8.35 previously.
For the second quarter of 2026, IDEX expects organic sales to increase 3-4% from the year-ago period and expects adjusted earnings in the range of $2.07-$2.12.
Zacks Rank and Stocks to ConsiderThe company currently carries a Zacks Rank #4 (Sell). Some better-ranked stocks are discussed below:
DXP Enterprises (DXPE - Free Report) presently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
DXP Enterprises’ earnings surpassed the consensus estimate by 52.8% in the last reported quarter. In the past 60 days, the Zacks Consensus Estimate for DXPE’s 2026 earnings has increased by 17.2%.
Nordson Corporation (NDSN - Free Report) currently carries a Zacks Rank #2 (Buy). Nordson’s earnings topped the consensus estimate in each of the trailing four quarters. The average earnings surprise was 2.5%. In the past 60 days, the Zacks Consensus Estimate for Nordson’s fiscal 2026 earnings has increased 0.5%.
RBC Bearings (RBC - Free Report) presently carries a Zacks Rank of 2. RBC Bearings’ earnings surpassed the consensus estimate in each of the trailing four quarters. The average earnings surprise was 5.3%. In the past 60 days, the Zacks Consensus Estimate for RBC Bearings’ fiscal 2026 earnings has inched down 0.3%.
NORTHBROOK, Ill.--(BUSINESS WIRE)--IDEX CORPORATION (NYSE:IEX) today announced that its Board of Directors has approved a regular quarterly cash dividend of $0.73 per common share. This dividend will be paid June 5, 2026 to shareholders of record as of May 22, 2026. This dividend represents the company’s 126th consecutive regular quarterly cash dividend payment.
IDEX Corp. (NYSE:IEX) announced a regular quarterly cash dividend of $0.73 per common share, its 126th consecutive regular quarterly payment.
Share About IDEX
IDEX Corporation (NYSE: IEX), a global engineered products company, is comprised of three primary business segments – Health & Science Technologies, Fluid & Metering Technologies, and Fire & Safety / Diversified Products. Thousands of IDEX employees around the world design and manufacture highly engineered components and applied solutions that are vital to the advances of modern life and help IDEX live its purpose – Trusted Solutions, Improving Lives™. From satellite communications to water systems, from medical diagnostic components to emergency rescue tools and more, we collaborate with customers in the most critical industries to develop solutions that make the world better today and into the future. Founded in 1988, IDEX now includes more than 50 dynamic businesses around the world and manufacturing operations in more than 20 countries. Learn more about the impactful work we do at www.idexcorp.com.
Investors interested in Industrial Products stocks should always be looking to find the best-performing companies in the group. Is Idex (IEX - Free Report) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out.
Idex is a member of our Industrial Products group, which includes 181 different companies and currently sits at #5 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Idex is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for IEX's full-year earnings has moved 3% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Our latest available data shows that IEX has returned about 18.7% since the start of the calendar year. At the same time, Industrial Products stocks have gained an average of 15%. This means that Idex is performing better than its sector in terms of year-to-date returns.
Another stock in the Industrial Products sector, Nordson (NDSN - Free Report) , has outperformed the sector so far this year. The stock's year-to-date return is 19.7%.
In Nordson's case, the consensus EPS estimate for the current year increased 1.2% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Idex belongs to the Manufacturing - General Industrial industry, which includes 41 individual stocks and currently sits at #80 in the Zacks Industry Rank. On average, this group has gained an average of 4.9% so far this year, meaning that IEX is performing better in terms of year-to-date returns. Nordson is also part of the same industry.
Investors interested in the Industrial Products sector may want to keep a close eye on Idex and Nordson as they attempt to continue their solid performance.
It has been about a month since the last earnings report for Idex (IEX - Free Report) . Shares have lost about 3.6% in that time frame, underperforming the S&P 500.
But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is Idex due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the latest earnings report in order to get a better handle on the important drivers.
IDEX Beats Q1 Earnings Estimates on HST Momentum, Raises ViewIDEX delivered first-quarter 2026 adjusted earnings of $2.00 per share, topping the Zacks Consensus Estimate of $1.78 by 12.4%. The metric rose 14.3% year over year. Net sales of $886.9 million beat the consensus mark of $835 million by 6.2% and increased 8.9% from the year-ago quarter.
Results were driven by solid traction in the Health & Science Technologies segment, where higher volumes in AI-linked data center power and semiconductor end markets, along with strength in space and defense, supported growth. IDEX also posted record orders, signaling improving demand early in 2026.
Organic sales increased 5% year over year. While acquisitions/divestitures had a positive impact on sales of 1%, foreign currency translation had a positive impact of 3% on sales.
Segmental DetailsNet sales from the Fluid & Metering Technologies segment totaled $301.5 million, up 4% year over year. Our estimate for segmental net sales was $297.3 million. Organic sales increased 2% year over year. Foreign currency translation had a positive impact of 2% on sales.
Net sales from the Health & Science Technologies segment totaled $398.4 million, up 17% year over year. Organic sales increased 11% year over year. Acquisitions/divestitures and foreign currency translation had a positive impact of 3% each on sales.
Net sales from the Fire & Safety/Diversified Products segment totaled $188.3 million, which increased 2% year over year. Our estimate for segmental net sales was $182 million. Organic sales decreased 1% on a year-over-year basis, while foreign currency translation had a favorable impact of 3% on sales.
Orders Signal Broad-Based DemandOrders increased 13% year over year to $988.3 million, with organic orders up 10%. Management pointed to momentum and backlog building in businesses tied to several end markets, particularly AI-driven areas, pharma and space and defense.
IDEX’s Margin ProfileIDEX’s cost of sales increased 9.7% year over year to $488.8 million. The adjusted gross margin was 44.9%, down 40 basis points year over year, reflecting unfavorable mix and higher costs, partially offset by productivity improvements and volume leverage. Selling, general and administrative expenses increased to $218.3 million from $209.4 million in the prior-year period.
Adjusted EBITDA rose 10.8% to $230.4 million and the adjusted EBITDA margin improved 50 basis points to 26%. Operating income increased 21.4% to $172.4 million, aided by stronger operating performance and a lower restructuring and asset impairment burden compared to the prior year period. The operating margin was 19.4%, up 200 bps year over year. Interest expenses (net) were relatively stable year over year at $16 million.
Cash Uses Highlight Shareholder ReturnsCash flows from operating activities were $103.7 million compared with $105.7 million a year ago, as increased earnings were offset by customer payment timing. Free cash flow declined 5.9% to $86 million, reflecting both working-capital timing and higher capital expenditures of $17.7 million.
The company continued to return capital, repurchasing $76.3 million of stock and paying $52.8 million in dividends during the quarter. On the balance sheet, cash and cash equivalents were $586.2 million exiting the first quarter, while long-term borrowings (net) stood at $1.87 billion.
IDEX’s Raised 2026 Outlook Reflects ConfidenceManagement raised full-year 2026 guidance, projecting organic sales growth of 3-4% compared with prior expectations of 1-2%. The company also lifted its full-year adjusted earnings outlook to $8.35-$8.55 per share from $8.15-$8.35 previously.
For the second quarter of 2026, IDEX expects organic sales to increase 3-4% from the year-ago period and expects adjusted earnings in the range of $2.07-$2.12.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a upward trend in estimates revision.
VGM ScoresAt this time, Idex has a subpar Growth Score of D, however its Momentum Score is doing a bit better with a C. Charting a somewhat similar path, the stock has a score of D on the value side, putting it in the bottom 40% for value investors.
Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending upward for the stock, and the magnitude of these revisions looks promising. It comes with little surprise Idex has a Zacks Rank #2 (Buy). We expect an above average return from the stock in the next few months.
Performance of an Industry PlayerIdex belongs to the Zacks Manufacturing - General Industrial industry. Another stock from the same industry, Applied Industrial Technologies (AIT - Free Report) , has gained 0.9% over the past month. More than a month has passed since the company reported results for the quarter ended March 2026.
Applied Industrial Technologies reported revenues of $1.25 billion in the last reported quarter, representing a year-over-year change of +7.3%. EPS of $2.65 for the same period compares with $2.57 a year ago.
Applied Industrial Technologies is expected to post earnings of $2.91 per share for the current quarter, representing a year-over-year change of +3.9%. Over the last 30 days, the Zacks Consensus Estimate has changed -0.2%.
The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for Applied Industrial Technologies. Also, the stock has a VGM Score of D.
The Industrial Products group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Idex (IEX - Free Report) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.
Idex is a member of our Industrial Products group, which includes 181 different companies and currently sits at #5 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. Idex is currently sporting a Zacks Rank of #2 (Buy).
Over the past three months, the Zacks Consensus Estimate for IEX's full-year earnings has moved 3% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
Based on the most recent data, IEX has returned 21.9% so far this year. At the same time, Industrial Products stocks have gained an average of 15.6%. As we can see, Idex is performing better than its sector in the calendar year.
Another Industrial Products stock, which has outperformed the sector so far this year, is TriMas (TRS - Free Report) . The stock has returned 15.7% year-to-date.
In TriMas' case, the consensus EPS estimate for the current year increased 5% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Idex belongs to the Manufacturing - General Industrial industry, which includes 41 individual stocks and currently sits at #93 in the Zacks Industry Rank. On average, stocks in this group have gained 6% this year, meaning that IEX is performing better in terms of year-to-date returns.
On the other hand, TriMas belongs to the Metal Products - Procurement and Fabrication industry. This 6-stock industry is currently ranked #29. The industry has moved +15.8% year to date.
Idex and TriMas could continue their solid performance, so investors interested in Industrial Products stocks should continue to pay close attention to these stocks.
